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ABSTRACT: Azides and nitriles are important building blocks for the synthesis of nitrogen-containing bioactive compounds. The 
first example of enantioselective palladium-catalyzed decarboxylative allylation of -azido and cyano -ketoesters is reported. In-
danone derivatives were obtained in 50-88% yield/77-97% ee and 46-98% yield/78-93% ee for azide and nitrile substituents, re-
spectively. The required starting materials were synthesized in one step from ketoesters via electrophilic azidation and cyanation 
using benziodoxole hypervalent iodine reagents. The products could be easily converted into useful nitrogen-containing building 
blocks, such as triazoles, amides or - and - amino ketones. 
Nitrogen-containing functional groups are omnipresent in 
synthetic and natural bioactive compounds. Among them, az-
ides1 and nitriles2 occupy a privileged position. They are high-
ly useful as non-basic precursors of amines. In addition, they 
can be transformed in a multitude of other functional groups 
and can be used in cycloaddition reactions to give a broad 
range of heterocycles (Figure 1). New methods giving access 
to nitriles and azides, especially in enantiopure form, are 
therefore highly useful for both synthetic and medicinal chem-
istry. Whereas numerous methods are available for the enanti-
oselective synthesis of secondary azides and nitriles, accessing 
tertiary derivatives is more challenging.  
Figure 1. Enantiopure tertiary azides and cyanides: versatile 
building blocks, but challenging to access.  
 
Among the methods used for the enantioselective synthesis 
of highly substituted stereocenters, the Tsuji-Trost palladium-
catalyzed decarboxylative allylation has been especially suc-
cessful.3 Nevertheless, to the best of our knowledge, this 
methodology has never been used for the synthesis of homoal-
lylic azides, and there are only racemic examples for cya-
nides.3c,4 This is an important limitation when considering the 
versatility of these building blocks. In general, the Tsuji-Trost 
decarboxylation has been only rarely used to synthesize homo- 
and bis-homo allylic amines.5 In 2015, Stoltz and co-workers, 
developed in particular an elegant Mannich addi-
tion/asymmetric decarboxylative allylation sequence to access 
bis-homo allylic amines.5d 
Indan(on)es are privileged structures in bioactive com-
pounds, and nitrogen-substituted derivatives are especially 
important.6 Nevertheless, the enantioselective synthesis of -
azido and cyano indanones has been limited to the azidation of 
ketoester derivatives7 and the conjugate addition or Mannich 
reaction of -cyano indanones.8 The Tsuji-Trost decarboxyla-
tion, although highly successful in the case of other type of 
substituents,3f,9 has never been reported in the case of cyanides 
and azides (Scheme 1). Herein, we would like to report the 
first example of highly enantioselective palladium-catalyzed 
decarboxylative allylation proceeding on cyano- and azido- 
substituted indanone derivatives. The required substrates were 
easily synthesized by the azidation or cyanation of ketoesters 
using hypervalent iodine reagents. 
Scheme 1. Enantioselective synthesis of indanones via the 
Tsuji-Trost decarboxylative allylation. 
 
We started our investigations with the synthesis of the re-
quired azido- and cyano- allyl ketoesters 4 and 5. The desired 
indanones could be accessed in good yield by the reaction with 
hypervalent iodine reagents 2 or 3 without any other additives 
using methods developed in our group10 and by Chen and co-
workers (Scheme 2).11 Unfortunately, the method could not be 
used to access the corresponding tetralones, due to competitive 
elimination and aromatization to naphthol derivatives. 
 Scheme 2. Synthesis of -azido and cyano allyl ketoesters 4 
and 5. 
 
We then turned to the optimization of the decarboxylative 
allylation for azide 4a (Table 1).12 When using 
Pd(Cp)Cinnamyl as catalyst precursor as in our previous work 
on the decarboxylative allylation of alkynyl-substituted ke-
toesters,9h only low conversion was observed. Better results 
were obtained using Pd2(dba)3 with Trost’s bisphosphine lig-
and 6a, and the desired product 7a was obtained in 31% yield 
and 71% ee, but 5 mol % catalyst were needed to reach full 
conversion (Table 1, entry 1).12 A strong dependence of both 
yield and enantioselectivity on solvent became apparent (Ta-
ble 1, entries 2-7). Whereas moderate yields and ee were ob-
served in toluene and acetonitrile (Table 1, entries 2 and 3), 
93% yield of 7a was obtained in dichloromethane, albeit at the 
cost of ee (Table 1, entry 4). From the tested ether solvents, 
THF gave the best result, with 88% yield and 79% ee (Table 1, 
entry 7). Other Trost bisphosphine ligands gave inferior results 
(Table 1, entries 8-10).13 Finally, the enantioselectivity could 
be improved to 86% by working in more concentrated solution 
at -20 °C (Table 1, entry 11). 
 
Table 1. Optimization of the decarboxylative allylation of az-
ide 4a. 
 
entry ligand solvent yield (%)a ee (%)b 
1 6a MTBE 31 71 
2 6a toluene 38 70 
3 6a CH3CN 50 68 
4 6a CH2Cl2 93 60 
5 6a Et2O 27 71 
6 6a dioxane 38 42 
7 6a THF 88 79 
8e 6b THF 10 30 
9 6c THF <5 nd 
10 6d THF 15 49 
11 6a THF 88 86c 
aReaction conditions: Substrate 4a (0.012 mmol), Pd2(dba)3 (5 
mol %), 6 (11 mol %) and solvent (0.2 M) at 25 °C. The NMR 
yield is measured in comparison with the internal standard 1,3,5-
trimethoxybenzene. bObtained by chiral HPLC. cAt 0.4 M at -20 
°C for 12 h. 
 
The scope of the decarboxylative allylation of azides was 
then examined (Scheme 3). The use of methallyl substrate 4b 
gave the desired product 7b in improved 97% ee. Product 7c 
and 7d bearing either a methyl group or no substituent in C5 
position also gave the products in good yield and enantioselec-
tivity. Interestingly, a 5-bromo group was also tolerated, de-
spite the fact that a palladium(0) catalyst is used (product 7e). 
Substitution at the C6 position was also possible, although in 
some cases lower yields and ee’s were obtained (products 7f-
i). The decarboxylative allylation was also successful with a 4-
bromo substituent (product 7j). Finally, the use of a more 
functionalized allyl group bearing a protected alcohol was also 
possible, as demonstrated by the formation of product 7k in 
51% yield and 95% ee.14 
Scheme 3. Scope of the decarboxylative allylation with azides 
4. Reaction conditions: Substrate 4 (0.20 mmol), Pd2(dba)3 (5 
mol %), 6a (11 mol %) and THF (0.4 M) at -20 °C, 10-15 h. 
The isolated yields after column chromatography are given. ee 
are obtained by chiral HPLC. 
 
In the case of cyano substrate 5a, the conditions used in our 
previous work for the decarboxylative allylation of -alkynyl 
allyl ketoesters (2 mol % Pd(Cp)Cinnamyl, 2.5 mol % 6a, 
MTBE, 0.1 M, rt) did not need to be changed extensively.9h,12 
In fact, working in more diluted conditions (0.01 M) and with 
higher catalyst/ligand loading (5 and 5.5 mol% respectively) 
was enough to give the desired allyl cyanides 8a in 91% yield 
and 80% ee (Scheme 4). For methallyl-based substrates, how-
ever, better results were obtained with Pd2dba3 as catalyst pre-
cursor (92% yield and 89% ee for 8b). Irrespectively of the 
 substitution pattern or electronic properties of the substituents 
on the benzene ring, the desired methallyl cyanides 8b-f were 
obtained in very good yields (81-98%), but the ee’s were low-
er than for azides (78-89%). Modification of the substituent on 
the alkene was also possible as a protected alcohol, an aryl or 
a chloride group (products 8g-i). Protected alcohol 8g was ob-
tained in 93% ee, which is the highest enantioselectivity ob-
served for this class of substrates. 
Scheme 4. Scope of the decarboxylative allylation with ni-
triles 5. Reaction conditions: Substrate 5 (0.20 mmol), 
Pd2(dba)3 (2.5 mol %), 6a (5.5 mol %) and THF (0.01 M) at 25 
°C, 6-48 h. The isolated yields after column chromatography 
are given. ee are obtained by chiral HPLC. aUsing 5 mol % 
PdCpCinnamyl as catalyst precursor. 
 
The obtained products could be easily transformed into use-
ful nitrogen-containing building blocks (Scheme 5).7b,15 Cop-
per-catalyzed [3+2]-cycloaddition of azides 7 with aromatic 
alkyne 9 gave triazoles 10a-c in 94-96% yield (Scheme 5, 
A).7b Staudinger reduction of azide 7e led to -amino ketone 
11,15a whereas hydrogenation of nitrile 8b gave -amino ke-
tone 12 (Scheme 5, B and C).15b Finally, amide 13 was ob-
tained in 83% yield by hydration of nitrile 8f in presence of a 
palladium catalyst (Scheme 5, D).15c 
In conclusion, we have reported the first example of enanti-
oselective palladium-catalyzed decarboxylative allylation pro-
ceeding next to cyano and azido groups. The reaction proceed-
ed with indanone derivatives in 50-88% yield/77-97% ee and 
46-98% yield/78-93% ee with azide and nitrile substituents, 
respectively. A broad range of functional groups was tolerated 
on the benzene ring and the alkene. The required indanone 
starting materials were obtained by the reaction of benziodox-
ole hypervalent iodine reagents with ketoesters. The obtained 
products were easily transformed into useful nitrogen-
containing building blocks, such as triazoles, amides and 
amines. 
Experimental procedures and analytical data for all new com-
pounds. This material is available free of charge via the Internet at 
http://pubs.acs.org.   
 
Scheme 5. Modifications of the obtained products. 
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). All chemicals were 
purchased from Acros, Aldrich, Fluka, VWR, Fluorochem, Aplichem or Merck and used without 
further purification, unless stated otherwise. Chromatographic purification was performed as 
flash chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as 
eluent with 0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC aluminium 
plates and visualized with UV light and anisaldehyde stain. Melting points were measured on a 
calibrated Büchi B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra 
were recorded on a Bruker DPX-400 400 MHz spectrometer in chloroform-d and/or DMSO-d6. 
All signals are reported in ppm with the internal chloroform signal at 7.26 ppm or the internal 
DMSO signal at 2.50 ppm as standard. The data is being reported as (s = singlet, d = doublet, t = 
triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, app = 
apparent, coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were recorded 
with 1H-decoupling on a Bruker DPX-400 100 MHz spectrometer in chloroform-d and/or 
DMSO-d6. All signals are reported in ppm with the internal chloroform signal at 77.0 ppm or the 
internal DMSO signal at 39.5 ppm as standard. Infrared spectra were recorded on a JASCO FT-
IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-
1 (w = weak, m = medium, s = strong, br = broad). Gas chromatographic and low resolution 
mass spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas 
chromatographer and mass spectrometer using a Perkin-Elmer Elite fused silica column (length: 
30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass spectrometric 
measurements were performed by the mass spectrometry service of ISIC at the EPFL on a 
MICROMASS (ESI) Q-TOF Ultima API. All the chiral ligands used in this work are 
commercially available. 
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2. Synthesis of Hypervalent Iodine Reagents  
2.1 Synthesis of 1-azido-3,3-dimethyl-3-(1H)-1,2-benziodoxole (2) 
1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (15) 
 
Following a reported procedure1 methyl 2-iodobenzoate (14) (12 mL, 76 mmol) was dissolved 
under N2 atmosphere in dry diethyl ether (400 mL) and then the solution was cooled to 0 °C with 
an ice bath. Methylmagnesium bromide (56.0 mL, 0.168 mol, 2.20 equiv.) was added dropwise 
and the reaction was stirred for 30 min at 0 °C. The reaction mixture was then allowed to warm to 
room temperature and it was further stirred for 2 h. The reaction was quenched with NH4Cl in an 
iced bath. The organic layer was separated and extracted with Et2O (3 x 100 mL), washed with 
water (2 x 200 mL), brine (1 x 100 mL) then dried over MgSO4. The solvent was removed in 
vacuo.  
With no further purification the crude mixture was dissolved in CCl4 (7 mL) and tert-butyl 
hypochlorite (0.010 L, 92 mmol, 1.2 equiv.) and the reaction mixture was stirred at room 
temperature. After one hour a yellow precipitate was collected by filtration and washed with 
hexane (60 mL) to afford compound 15 (7.7 g, 26 mmol, 34% yield) as a yellow solid. 
1H NMR (400 MHz, CDCl3) δ 8.03 (dd, 1 H, J = 8.1, 1.1 Hz, CHAr), 7.55 (m, 2 H, CHAr), 7.17 
(dd, 1 H, J = 7.3, 1.7 Hz, CHAr), 1.55 (s, 6 H, (CH3)2).
  
13C NMR (101 MHz, CDCl3) δ 149.5, 131.0, 130.5, 128.4, 126.1, 114.7, 85.2, 29.2.  
IR νmax 3729 (w), 3626 (w), 2972 (w), 2924 (w), 2362 (w), 2055 (w), 2018 (w), 1742 (w), 1564 
(w), 1464 (w), 1439 (w), 1379 (w), 1378 (w), 1366 (w), 1277 (w), 1276 (w), 1256 (w), 1181 (w), 
1154 (m), 1112 (w), 1048 (w), 1003 (w), 982 (w), 943 (m), 866 (m), 808 (w), 790 (w), 789 (w), 
762 (s), 745 (w), 724 (w), 718 (w).  
The characterization data is in accordance with reported literature values.1 
1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (16) 
 
Following a reported procedure,1 1-chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (15) (2.60 
g, 8.77 mmol) was dissolved in dry acetonitrile (25 mL) under N2 atmosphere. The reaction flask 
was covered with aluminum foils and protected from light. Silver acetate (1.46 g, 8.77 mmol, 
1.00 equiv.) was then added in one portion. The reaction mixture was stirred in the dark at room 
                                                 
1 S. Akai, T. Okuno, M. Egi, T. Takada, H. Tohma, Y. Kita, Heterocycles 1996, 42, 47. 
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temperature for 16 h. Filtration over a Celite plug and evaporation of the solvent yielded 
compound 16 (2.6 g, 8.8 mmol, 93%) as a brownish solid. 
 
1H NMR (400 MHz, CDCl3) δ 7.79 (dd, 1 H, J = 8.0, 1.3 Hz, CHAr), 7.47 (m, 2H, CHAr), 7.18 
(dd, 1 H, J = 7.2, 1.7 Hz, CHAr), 2.11 (s, 3 H, COCH3), 1.52 (s, 6 H, (CH3)2). 
 
 13C NMR (101 MHz, CDCl3) δ 177.4, 149.4, 130.4, 130.0, 129.9, 126.2, 115.7, 84.6, 29.2, 21.5.  
IR νmax 3099 (w), 3057 (w), 2975 (w), 2930 (w), 2930 (w), 2865 (w), 1740 (w), 1640 (s), 1588 
(w), 1566 (w), 1462 (w), 1438 (m), 1363 (s), 1294 (s), 1259 (m), 1158 (m), 1114 (w), 1047 (w), 
1033 (w), 1009 (w), 949 (m), 926 (w), 866 (w), 761 (s), 723 (w).  
The characterization data is in accordance with reported literature values.1 
1-Azido-3,3-dimethyl-3-(1H)-1,2-benziodoxole (2) 
 
Caution: This reaction should be carried out behind a safety shield! Following a reported 
procedure1 1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (16) (2.30 g, 7.18 mmol) was 
dissolved in dry CH2Cl2 (36 mL) under N2 atmosphere. The reaction was placed in an iced bath 
and trimethylsilylazide (0.954 mL, 7.18 mmol, 1.00 equiv.) was added via syringe, followed by 
TMSOTf (0.065 mL, 0.36 mmol, 0.050 equiv.). The reaction was stirred for 15 min then the ice 
bath was removed and the stirring was continued for 1 h. The solvent was evaporated and the 
solid obtained was washed with n-hexane (2 x 30 mL, HLPC purity) to afford 2 as a yellow 
crystalline solid (2.10 g, 7.18 mmol, 96%). 
1H NMR (400 MHz, CDCl3) δ 7.77 (d, 1 H, J = 8.0 Hz, CHAr), 7.55 (m, 2 H, CHAr), 7.23 (d, 1 
H, J = 7.2 Hz, CHAr), 1.53 (s, 7 H, (CH3)2.  
13C NMR (101 MHz, CDCl3) δ 149.2, 130.9, 130.4, 127.8, 126.8, 114.0, 83.2, 29.6.  
IR νmax 3254 (w), 3085 (w), 3051 (w), 2976 (w), 2928 (w), 2860 (w), 2486 (w), 2026 (s), 1918 
(w), 1764 (w), 1697 (w), 1651 (w), 1589 (w), 1562 (w), 1462 (m), 1428 (m), 1380 (w), 1364 (w), 
1312 (w), 1273 (w), 1248 (s), 1182 (w), 1151 (m), 1111 (m), 1031 (w), 1004 (w), 943 (m), 910 
(m), 880 (w), 863 (m).  
The characterization data is in accordance with reported literature values.1 
2.2 Synthesis of 1-Cyano-1,2-benziodoxol-3-(1H)-one (3) 
 
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (18) 
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Following a reported procedure,2 NaIO4 (25.8 g, 121 mmol, 1.05 eq.) and 2-iodobenzoic acid 
(17) (28.5 g, 115 mmol, 1.00 eq.) were suspended in 30% (v:v) aq. AcOH (175 mL). The mixture 
was vigorously stirred and refluxed for 4 h. The reaction mixture was then diluted with cold 
water (500 mL) and allowed to cool to room temperature, while protecting it from light. After 1 
h, the crude product was collected by filtration. The crystals were washed with ice water (3 x 100 
mL) followed by acetone (3 x 100 mL) and then air-dried in the dark affording 18 (29.3 g, 111 
mmol, 96.5%) as a white solid.  
 
1H NMR (400 MHz, DMSO-d6) δ 8.04 (s, 1 H, OH), 8.01 (dd, 1 H, J = 7.6, 1.5 Hz, ArH), 7.96 
(ddd, 1 H, J = 8.5, 7.2, 1.5 Hz, ArH), 7.84 (dd, 1 H, J = 8.2, 0.7 Hz, ArH), 7.70 (td, 1 H, J = 7.3, 
1.1 Hz, ArH).  
 
13C NMR (100 MHz, (DMSO-d6) δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4.  
 
IR νmax 3083 (w), 3060 (w), 2867 (w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 
(s), 1302 (m), 1148 (m), 1018 (w), 834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m). 
 
The characterization data is in accordance with reported literature values.3 
 
1-Acetoxy-1,2-benziodoxol-3-(1H)-one (19) 
 
 
 
Following a reported procedure,4 1-hydroxy-1,2-benziodoxol-3-(1H)-one (18), 10.3 g, 39.1 
mmol, 1.00 equiv.) was suspended in acetic anhydride (35 mL) and heated to reflux for 30 
minutes. The resulting clear, slightly yellow solution was slowly let to warm up to room 
temperature and then cooled to 0 °C for 30 minutes. The white suspension was filtered and the 
filtrate was again cooled to 0 °C for 30 minutes. The suspension was once again filtered and the 
combined two batches of solid product were washed with hexane (2 x 20 mL) and dried in vacuo 
affording 19 (10.8 g, 35.3 mmol, 90%) as a white solid. 
 
1H NMR (CDCl3, 400 MHz) δ 8.24 (dd, 1 H, J = 7.6, 1.6 Hz, ArH), 8.00 (dd, 1 H, J = 8.3, 1.0 
Hz, ArH), 7.92 (ddd, 1 H, J = 8.4, 7.2, 1.6 Hz, ArH), 7.71 (td, 1 H, J = 7.3, 1.1 Hz, ArH), 2.25 (s, 
3 H, COCH3). 
 
                                                 
2
 L. Kraszkiewicz, L. Skulski, Arkivoc 2003, 120. 
3
 J. P. Brand, J. Charpentier, J. Waser, Angew. Chem. Int. Ed. 2009, 48, 9346. 
4
 P. Eisenberger, S. Gischig, A. Togni, Chem. Eur. J. 2006, 12, 2579. 
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 13C NMR (CDCl3, 100 MHz) δ 176.5, 168.2, 136.2, 133.3, 131.4, 129.4, 129.1, 118.4, 20.4.  
 
The characterization data is in accordance with reported literature values.4 
 
1-Cyano-1,2-benziodoxol-3-(1H)-one (3) 
 
 
 
Following a reported procedure,1 1-acetoxy-1,2-benziodoxol-3-(1H)-one (19), 10.5 g, 34.3 mmol, 
1.00 equiv.) was dissolved under nitrogen in dry dichloromethane (80 mL). To the clear colorless 
solution was added via syringe trimethylsilyl cyanide (TMS-CN, 9.20 mL, 68.6 mmol, 2.00 
equiv.) over a five minute time period. The reaction mixture was stirred at room temperature and 
under nitrogen for 72 hours. The resulting thick white suspension was filtered and the solid was 
washed with hexane (3 x 20 mL) and dried in vacuo affording 3 (8.89 g, 32.6 mmol, 95%) as a 
white solid.  
 
1H NMR (DMSO-d6, 400 MHz): δ 8.29 (d, 1 H, J = 8.3 Hz, ArH), 8.13 (dd, 1 H, J = 7.4, 1.7 Hz, 
ArH), 8.06-7.97 (m, 1 H, ArH), 7.88 (t, 1 H, J = 7.3 Hz, ArH).  
 
13C NMR (DMSO-d6, 100 MHz): δ 166.7, 136.5, 132.0, 131.9, 130.2, 127.8, 117.5, 87.9.  
 
IR νmax 3157 (w), 3093 (w), 2160 (w), 1629 (s), 1562 (m), 1439 (m), 1321 (s), 1298 (s), 1148 
(m), 839 (m), 747 (s).  
 
The characterization data is in accordance with reported literature values.1   
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3. Synthesis of starting materials allyl β-keto esters.  
General procedure GP1 for the synthesis of β-allyl keto esters. 
 
Following a reported procedure,5 potassium tert-butoxide (0.05 equiv) was added to a suspension 
of NaH (2.2 equiv) in diallyl carbonate 21 (2.0 equiv). The ketone 20 (1.0 equiv) was then added 
dropwise at 0 °C. The reaction was stirred at room temperature and followed by TLC (using the 
solvent mixture indicated below for the Rf value and UV or p-anisaldehyde stain for 
visualization). Then 1 M HCl was added until the pH of the solution became neutral or slightly 
acidic. The organic layers were collected and washed with brine (2 x 20 mL), dried over MgSO4 
and concentrated in vacuo. The crude product was purified by column chromatography, using the 
solvent indicated for the RF value. 
 
Allyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1a) 
Following general procedure GP1, starting from commercially available 5-methoxy-2,3-dihydro-
1H-inden-1-one (20a) (0.200 g, 1.23 mmol), allyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1a) (0.209 g, 0.851 mmol, 69% yield) was obtained as a brown solid.  
RF 0.3 (Pentane:Ethyl Acetate 3:2) 
Mp: 53.5-55.9° C. 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 9.2 Hz, 1H, ArH), 6.96 – 6.89 (m, 2H, ArH), 
5.94 (ddt, J = 17.3, 10.5, 5.6 Hz, 1H, CHCH2), 5.37 (dq, J = 17.2, 1.5 Hz, 1H, CHCH2), 5.25 (dq, 
J = 10.5, 1.3 Hz, 1H, CHCH2), 4.69 (tt, J = 5.7, 1.4 Hz, 2H, CH2CH), 3.90 (s, 3H, OMe), 3.74 
(dd, J = 8.2, 4.0 Hz, 1H, CH), 3.52 (dd, J = 17.3, 4.0 Hz, 1H, CH2), 3.32 (dd, J = 17.3, 8.2 Hz, 
1H, CH2). 
13C NMR (101 MHz, Chloroform-d) δ 197.4, 169.1, 165.9, 156.7, 131.7, 128.5, 126.4, 118.6, 
116.0, 109.6, 66.2, 55.8, 53.5, 30.3. 
IR νmax 3021 (w), 3013 (w), 2842 (w), 1738 (m), 1705 (s), 1598 (s), 1491 (w), 1337 (w), 1307 
(m), 1259 (s), 1224 (w), 1193 (m), 1156 (m), 1149 (m), 1105 (m), 1089 (m), 1025 (m), 989 (m). 
The characterization data is corresponding to the reported values.6 
 
                                                 
5 M.V. Vita, J. Waser, Org. Lett. 2013, 15, 3246. 
6 M.V. Vita, J. Waser, Org. Lett. 2014, 16, 5768. 
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2-Methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1b) 
Following general procedure GP1, starting from commercially available 5-methoxy-2,3-dihydro-
1H-inden-1-one (20b) (1.76 g, 10.9 mmol), 2-methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1b) (2.17 g, 8.34 mmol, 77% yield) was obtained as a yellowish oil.  
RF 0.6 (Pentane:Ethyl Acetate 7:3).  
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 9.1 Hz, 1H, ArH), 6.96-6.92 (m, 2H, ArH), 
5.03 (dd, J = 1.6, 0.9 Hz, 1H, CMeCH2), 4.94 (m, 1H, CMeCH2), 4.68 – 4.54 (m, 2H, CH2CMe), 
3.90 (s, 3H, OCH3), 3.78 (dd, 1 H, J = 8.2, 4.0 Hz, CH), 3.55 (dd, 1 H, J = 17.3, 4.0 Hz, CH2), 
3.35 (dd, 1 H, J = 17.3, 8.2 Hz), 1.78 (dd, J = 1.6, 0.9 Hz, 3H, CCH3). 
13C NMR (101 MHz, Chloroform-d) δ 197.3, 169.1, 165.9, 156.7, 139.6, 128.6, 126.4, 116.0, 
113.3, 109.6, 68.7, 55.8, 53.5, 30.3, 19.5. 
IR νmax 2978 (w), 2969 (w), 2942 (w), 1740 (m), 1706 (s), 1600 (s), 1306 (w), 1261 (s), 1156 
(m), 1090 (m). 
The characterization data is corresponding to the reported values.6 
 
2-Methylallyl 5-methyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1c) 
 
Following general procedure GP1, starting from commercially available 5-methyl-2,3-dihydro-
1H-inden-1-one (20c) (0.50 g, 3.4 mmol), 2-methylallyl 5-methyl-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (1c) (0.60 g, 2.3 mmol, 67% yield) was obtained as a orange oil. 
RF 0.66 (Pentane:Ethyl Acetate 4:1).  
 
1H NMR (400 MHz, Chloroform-d) δ 7.66 (d, J = 7.9 Hz, 1H, ArH), 7.30 (s, 1H, ArH), 7.20 (d, 
J = 7.9 Hz, 1H, ArH), 5.02 (s, 1H, CMeCH2), 4.96 – 4.89 (m, 1H, CMeCH2), 4.69 – 4.52 (m, 2H, 
CH2CMe), 3.75 (dd, J = 8.2, 4.0 Hz, 1H, CH), 3.60 – 3.44 (m, 1H, CH2), 3.33 (dd, J = 17.2, 8.2 
Hz, 1H, CH2), 2.45 (s, 3H, CH3), 1.77 (s, 3H, CH3). 
  
13C NMR (101.00 MHz, Chloroform-d) δ 198.8, 169.0, 154.1, 146.8, 139.6, 133.0, 129.1, 
126.9, 124.5, 113.3, 68.7, 53.5, 30.2, 22.2, 19.5. 
 
IR νmax 2933 (w), 1741 (m), 1712 (s), 1609 (m), 1269 (m), 1233 (m), 1196 (m), 1155 (m), 910 
(w), 909 (w).  
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HRMS (ESI) calcd for C15H17O3
+ [M+H]+ 245.1172; found 245.1177. 
 
2-Methylallyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1d) 
Following general procedure GP1, starting from commercially available 2,3-dihydro-1H-inden-
1-one (20d) (0.500 g, 3.78 mmol), 2-methylallyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate 
(1d) (0.653 g, 2.84 mmol, 75% yield) was obtained as a purple liquid.  
RF 0.3 (Pentane:Ethyl Acetate 3:2).  
1H NMR (400 MHz, Chloroform-d) (Ketone/Enol 1:0.2) Ketone: δ 7.78 (d, J = 7.7 Hz, 1H, 
ArH), 7.63 (dd, J = 8.1, 6.8 Hz, 1H, ArH), 7.51 (d, J = 7.7 Hz, 1H, ArH), 7.43 – 7.36 (m, 1H, 
ArH), 5.05 – 4.91 (m, 2H, CMeCH2), 4.72 – 4.52 (m, 2H, CH2CMe), 3.77 (dd, J = 8.3, 4.1 Hz, 
1H, CHCH2), 3.64 – 3.52 (m, 1H, CH2CH), 3.40 (dd, J = 17.2, 8.2 Hz, 1H, CH2CH), 1.78 (d, J = 
1.4 Hz, 3H, CMe). Enol: δ 7.65 (m, 1H, ArH), 7.47 (d, J = 1.3 Hz, 1H, ArH), 7.44 (dd, J = 7.3, 
1.4 Hz, 1H, ArH), 7.39 (m, 1H, ArH), 5.05 (d, J = 1.5 Hz, 1H, CMeCH2), 4.98 (t, J = 1.4 Hz, 1H, 
CMeCH2), 4.69 (s, 2H, CH2CMe), 3.56 (s, 2H, CH2 ), 1.82 (s, 3H, CMe). 
13C NMR (101.00 MHz, Chloroform-d) Ketone: δ 199.3, 168.8, 153.5, 139.5, 135.4, 135.3, 
127.9, 126.6, 124.7, 113.4, 68.8, 53.3, 30.3, 19.5. Enol: δ 143.2, 140.0, 136.9, 129.5, 126.9, 
124.8, 120.8, 112.8, 102.2, 67.1, 32.5, 29.7.7  
IR νmax 1746 (s), 1716 (s), 1464 (w), 1328 (w), 1314 (w), 1300 (w), 1286 (w), 1274 (w), 1248 
(w), 1207 (m), 1186 (m), 1155 (m), 1128 (w), 991 (w), 990 (w), 917 (w), 908 (w), 765 (m). 
The characterization data is corresponding to the reported values.6 
2-Methylallyl 5-bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1e) 
Following general procedure GP1, starting from commercially available 5-bromo-2,3-dihydro-
1H-inden-1-one (20e) (0.500 g, 2.37 mmol), 2-methylallyl 5-bromo-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1e) (0.501 g, 1.62 mmol, 68% yield) was obtained as a yellow solid. 
RF 0.3 (Pentane:Ethyl acetate 3:2).  
Mp: 58.2-61.9 °C. 
                                                 
7 2C in the enol are missing, one possibly the ester. 
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1H NMR (400 MHz, Chloroform-d) Ketone/Enol form (1.5:1) Ketone: δ 7.69 (d, J = 1.6 Hz, 
1H, ArH), 7.63 (d, J = 8.2 Hz, 1H, ArH), 7.56 – 7.51 (m, 1H, ArH), 5.02 (s, 1H, CCH2), 4.95 (s, 
1H, CCH2), 4.68 – 4.54 (m, 2H, CH2C), 3.77 (dd, J = 8.3, 4.1 Hz, 1H, CH), 3.54 (dd, J = 17.4, 
4.0 Hz, 1H, CH2), 3.37 (dd, J = 17.5, 8.3 Hz, 1H, CH2), 1.79 – 1.76 (m, 3H, CCH3). Enol: δ 10.31 
(s, 1H, OH), 7.62 (s, 1H, ArH), 7.52 – 7.50 (m, 2H, ArH), 5.05 – 5.03 (m, 1H, CCH2), 4.98 (t, J = 
1.4 Hz, 1H, CCH2), 4.69 (s, 2H, CH2C), 3.53 (s, 2H, CH2), 1.82 (t, J = 1.1 Hz, 3H, CCH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 198.0, 168.3, 155.1, 144.9, 139.9, 139.4, 135.9, 
134.1, 131.6, 131.0, 130.2, 129.9, 128.1, 125.8, 124.0, 122.0, 113.5, 113.0, 102.5, 68.9, 67.3, 
53.3, 32.4, 30.0, 19.5, 19.5. 28  
IR νmax 2977 (w), 2940 (w), 2934 (w), 1742 (m), 1717 (s), 1652 (m), 1620 (m), 1597 (m), 1562 
(m), 1418 (m), 1316 (m), 1288 (m), 1260 (m), 1211 (s), 1200 (s), 1179 (s), 1159 (m), 1133 (m), 
1101 (m), 992 (m), 911 (m). 
The characterization data is corresponding to the reported values.6 
2-Methylallyl 6-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1f) 
Following general procedure GP1, starting from commercially available 6-methoxy-2,3-dihydro-
1H-inden-1-one (20f) (0.30 g, 1.9 mmol), 2-methylallyl 6-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1f) (0.30 g, 1.2 mmol, 66% yield) was obtained as a pink oil.  
RF 0.43 (pentane: ethyl acetate 8:2).  
 
1H NMR (400 MHz, Chloroform-d) (Ketone/Enol 1:0.2) Ketone δ 7.39 (dq, J = 8.3, 0.8 Hz, 1H, 
ArH), 7.22 (dd, J = 8.3, 2.6 Hz, 1H, ArH), 7.19 (d, J = 2.5 Hz, 1H, ArH), 5.03 (s, 1H, CMeCH2), 
4.94 (s, 1H, CMeCH2), 4.68 – 4.52 (m, 2H, CH2CMe), 3.83 (s, 3H, OMe), 3.79 (dd, J = 8.1, 3.9 
Hz, 1H, CH), 3.48 (ddd, J = 17.0, 4.0, 1.0 Hz, 1H, CH2), 3.32 (ddd, J = 16.9, 8.1, 0.9 Hz, 1H, 
CH2), 1.78 (s, 3H, CH3). Enol δ 10.38 (s, 1H, OH), 7.35 (dd, J = 8.3, 0.7 Hz, 1H, ArH), 7.16 (d, J 
= 2.4 Hz, 1H, ArH), 7.00 (dd, J = 8.3, 2.5 Hz, 1H, ArH), 5.05 – 5.04 (m, 1H, CMeCH2), 4.97 
(ddd, J = 2.5, 1.7, 1.0 Hz, 1H, CMeCH2), 4.69 (s, 2H, CH2CMe), 3.86 (s, 3H, OMe), 3.50 (s, 2H, 
CH2), 1.82 (dd, J = 1.6, 0.9 Hz, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) Ketone δ 199.3, 168.9, 159.7, 146.5, 139.5, 136.5, 127.2, 
125.0, 113.4, 105.7, 68.8, 55.7, 54.0, 29.7, 19.5. Enol δ 159.2, 140.0, 138.0, 135.5, 125.4, 117.2, 
112.8, 104.5, 103.3, 67.1, 55.6, 31.8, 19.5. 9 
 
IR νmax 2942 (w), 2941 (w), 1740 (m), 1711 (s), 1493 (w), 1438 (w), 1277 (m), 1229 (m), 1211 
(m), 1187 (w), 1186 (w), 1156 (m), 1029 (w), 910 (s), 733 (s). 
 
HRMS (ESI) calcd for C15H16NaO4
+ [M+Na]+ 283.0941; found 283.0940. 
  
 
                                                 
8 Aromatic C of the enol form are not resolved. 
9 2 C in the aromatic region of the enol form are not resolved. 
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2-Methylallyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1g) 
Following general procedure GP1, starting from commercially available 6-chloro-2,3-dihydro-
1H-inden-1-one (20g) (0.50 g, 3.0 mmol), 2-methylallyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (1g) (0.59 g, 2.2 mmol, 74% yield) was obtained as pink solid.  
RF 0.3 (Pentane:Ethyl Acetate 3:2).  
Mp: 71.5-73.7° C. 
1H NMR (400 MHz, Chloroform-d) Ketone/enol ratio (1:0.5) Ketone δ 7.73 (d, J = 2.1 Hz, 1H, 
ArH), 7.58 (dd, J = 8.2, 2.1 Hz, 1H, ArH), 7.39 (d, J = 1.3 Hz, 1H, ArH), 5.04 – 5.00 (s, 1H, 
CCH2), 4.97 – 4.93 (s, 1H, CCH2), 4.68 – 4.52 (m, 2H, CH2C), 3.80 (dd, J = 8.2, 4.0 Hz, 1H, 
CH), 3.54 (dd, J = 17.3, 4.0, 1H, CH2), 3.36 (dd, J = 17.4, 8.1 Hz, 1H, CH2), 1.77 (s, 3H, CCH3). 
Enol: δ 10.25 (s, 1H, OH), 7.62 (s, 1H, ArH), 7.45 (d, J = 8.1 Hz, 2H, ArH), 5.05 (s, 1H, CCH2), 
4.98 (s, 1H, CCH2), 4.69 (s, 2H, CH2C), 3.54 (s, 2H, CH2), 1.82 (d, J = 1.5 Hz, 3H, CCH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 198.0, 168.3, 151.6, 141.2, 139.9, 139.4, 138.6, 
136.8, 135.5, 134.3, 133.1, 129.4, 127.7, 125.8, 124.4, 120.9, 113.5, 113.0, 103.7, 69.0, 67.3, 
53.7, 32.3, 29.9, 19.5, 19.4.10  
IR νmax 2975 (w), 2935 (w), 2861 (w), 2860 (w), 1745 (m), 1720 (s), 1652 (m), 1620 (m), 1592 
(m), 1568 (m), 1339 (m), 1255 (s), 1201 (s), 1187 (s), 1166 (m), 1131 (m), 1107 (m), 907 (w), 
777 (w). 
The characterization data is corresponding to the reported values.6 
2-Methylallyl 6-trifluoromethyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1h) 
Following general procedure GP1, starting from commercially available 6-(trifluoromethyl)-2,3-
dihydro-1H-inden-1-one (20h) (0.23 mL, 1.5 mmol), 2-methylallyl 1-oxo-6-(trifluoromethyl)-
2,3-dihydro-1H-indene-2-carboxylate (1h) (0.32 g, 1.1 mmol, 71% yield) was obtained as pink 
solid.  
                                                 
10 2 aromatic C of the enol form are not resolved. 
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RF 0.25 (Pentane:Ethyl Acetate 9:1).  
Mp: 56.7-59.2° C. 
1H NMR (400 MHz, Chloroform-d) (Ketone/enol 0.5:1) Ketone δ 8.05 (d, J = 1.7 Hz, 1H, 
ArH), 7.66 (d, J = 8.2 Hz, 2H, ArH), 5.05 – 5.02 (m, 1H, CCH2), 4.96 (t, J = 1.5 Hz, 1H, CCH2), 
4.65 (s, 1H, CH2CMe), 4.58 (d, J = 13.0 Hz, 1H, CH2CMe), 3.85 (dd, J = 8.3, 4.0 Hz, 1H, CH2), 
3.71 – 3.64 (m, 1H, CH2), 3.46 (dd, J = 17.7, 7.9 Hz, 1H, CH2), 1.81 – 1.76 (m, 3H, CH2CMe). 
Enol: δ 10.29 (s, 1H, OH), 7.93 – 7.90 (m, 1H, ArH), 7.88 (dd, J = 8.2, 1.7 Hz, 1H, ArH), 7.59 
(d, J = 7.9 Hz, 1H, ArH), 5.06 (p, J = 1.2 Hz, 1H, CMeCH2), 5.00 (q, J = 1.3 Hz, 1H, CMeCH2), 
4.71 (s, 2H, CH2CMe), 3.63 (s, 2H, CH2), 1.86 – 1.80 (m, 3H, CCH3). 
13C NMR (101 MHz, Chloroform-d) δ 198.0, 168.6, 168.5, 168.1, 156.6, 146.5, 139.8, 139.3, 
137.6, 135.7, 131.9 (q, J = 3.6 Hz), 130.7 (t, J = 33.1 Hz), 129.7 (d, J = 32.4 Hz), 127.4, 126.10 
(q, J = 3.8 Hz), 125.1, 124.2 (q, J = 272.2 Hz), 123.6 (q, J = 273 Hz), 122.0 (q, J = 4.0 Hz), 117.9 
(q, J = 3.9 Hz), 113.6, 113.1, 103.7, 69.1, 67.4, 53.5, 32.8, 30.4, 19.5, 19.4. 
19F NMR (376 MHz, CDCl3) δ -62.1, -62.6.  
IR νmax 2944 (w), 1724 (m), 1657 (m), 1324 (s), 1269 (s), 1254 (m), 1215 (m), 1189 (m), 1164 
(s), 1128 (s), 1103 (s), 909 (m). 
The characterization data is corresponding to the reported values.6 
2-Methylallyl 6-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1i) 
Following general procedure GP1, starting from commercially available 5-fluoro-2,3-dihydro-
1H-inden-1-one (20i) (0.50 g, 3.3 mmol), 2-methylallyl 5-fluoro-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1i) (0.50 g, 1.9 mmol, 57% yield) was obtained as a brown oil. 
 
RF 0.3 (Dichloromethane:Pentane 3:2).  
 
1H NMR (400 MHz, Chloroform-d) (Ketone/Enol 1:0.4) Ketone δ 7.48 (dd, J = 8.4, 4.4 Hz, 1H, 
ArH), 7.41 (dd, J = 7.3, 2.4 Hz, 1H, ArH), 7.36 (dd, J = 8.5, 2.6 Hz, 1H, ArH), 5.03 (s, 1H, 
CCH2), 4.95 (s, 1H, CCH2), 4.68 – 4.54 (m, 2H, OCH2), 3.82 (dd, J = 8.2, 4.0 Hz, 1H, CH), 3.58 
– 3.49 (m, 1H, CH2), 3.36 (ddt, J = 17.1, 8.2, 1.2 Hz, 1H, CH2), 1.78 (t, J = 1.1 Hz, 3H, CH3). 
Enol δ 7.39 (m, 1H, ArH), 7.34 – 7.30 (m, 1H, ArH), 7.12 (ddd, J = 9.3, 8.3, 2.5 Hz, 1H, ArH), 
5.05 (t, J = 1.2 Hz, 1H, CCH2), 4.98 (t, J = 1.4 Hz, 1H, CCH2), 4.70 (s, 2H, OCH2C), 3.51 (s, 2H, 
CH2), 1.82 (t, J = 1.1 Hz, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) Ketone: δ 198.3, 168.4, 162.5 (d, J = 248.8 Hz), 148.9 (d, 
J = 2.2 Hz), 139.4, 137.0 (d, J = 7.7 Hz), 127.9 (d, J = 8.0 Hz), 123.2 (d, J = 23.8 Hz), 113.5, 
110.5 (d, J = 22.2 Hz), 68.9, 54.1, 29.8, 19.4. Enol: δ 162.3 (d, J = 244.7 Hz), 148.9, 139.9, 
S14 
 
138.7, 138.5 (d, J = 2.4 Hz), 125.8 (d, J = 8.8 Hz), 116.6 (d, J = 23.3 Hz), 113.0, 107.7 (d, J = 
23.8 Hz), 104.1, 67.3, 32.0, 19.5.11  
 
IR νmax 3075 (w), 2937 (w), 1742 (m), 1718 (s), 1655 (m), 1577 (m), 1488 (m), 1262 (s), 1198 
(s), 1147 (s). 
HRMS (ESI) calcd for C14H14FO3
+ [M+H]+ 249.0921; found 249.0927 
 
2-Methylallyl 4-bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1j) 
Following general procedure GP1, starting from commercially available 4-bromo-2,3-dihydro-
1H-inden-1-one (20j) (0.50 g, 2.4 mmol), 2-methylallyl 4-bromo-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (1j) (0.60 g, 2.0 mmol, 83% yield) was obtained as a pink solid.  
RF 0.3 (Pentane:Ethyl Acetate 9:1).  
 
Mp: 51-54° C. 
 
1H NMR (400 MHz, Chloroform-d) (Ketone/Enol 1:0.5) Ketone δ 7.90 (dd, J = 7.8, 0.9 Hz, 1H, 
ArH), 7.41 (dd, J = 8.9, 7.0 Hz, 1H, ArH), 7.38 (d, J = 9.5 Hz, 1H, ArH), 5.14 (t, J = 1.3 Hz, 1H, 
CMeCH2), 5.06 (s, 1H, CMeCH2), 4.77 (d, J = 13.0 Hz, 1H, CH2CMe), 4.69 (d, J = 13.0 Hz, 1H, 
CH2CMe), 3.91 (dd, J = 8.3, 4.0 Hz, 1H, CH), 3.60 (m, 1H, CH2), 3.44 (dd, J = 17.8, 8.3 Hz, 1H, 
CH2), 1.89 (t, J = 1.1 Hz, 3H, CH3). Enol δ 10.40 (s, 1H, OH), 7.83 (d, J = 7.5 Hz, 1H, ArH), 
7.68 (m, 2H, ArH), 5.16 (t, J = 1.4 Hz, 1H, CMeCH2), 5.12 – 5.07 (m, 1H, CMeCH2), 4.81 (s, 
2H, CH2CMe), 3.62 (s, 2H, CH2), 1.94 (d, J = 1.3 Hz, 3H, CH3). 
 
13C NMR (101.00 MHz, Chloroform-d) Ketone: δ 198.5, 168.3, 138.2, 132.5, 129.6, 128.8, 
123.51, 119.9, 113.6, 113.1, 69.0, 53.2, 31.4, 19.5. Enol: δ 153.2, 143.1, 139.9, 139.4, 138.5, 
137.2, 122.0, 119.7, 102.9, 67.4, 34.1, 19.5.12 
 
IR νmax 3082 (w), 2979 (w), 1748 (s), 1723 (s), 1656 (m), 1563 (m), 1456 (m), 1262 (s), 1235 (s), 
1188 (s), 910 (m), 772 (m). 
 
HRMS (ESI) calcd for C14H13
79BrNaO3
+ [M+Na]+ 330.9940; found 330.9943 
 
 
 
                                                 
11 1C in the enol form is not resolved. 
12 Two C of the aromatic region of the enol form are not resolved. 
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3.1 Synthesis of substrates 1k, 1l and 1m. 
 
Ethyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (26) 
Following a reported procedure,13 potassium tert-butoxide (6.9 mg, 0.062 mmol, 0.0050 equiv.) 
was added to a suspension of NaH (1.1 g, 27 mmol, 2.2 equiv.) and diethyl carbonate (7.5 mL, 62 
mmol, 5.0 equiv.). Commercially available 5-Methoxy-2,3-dihydro-1H-inden-1-one (20b) (2.0 g, 
12 mmol) was then added carefully at 0 °C. The reaction was stirred at room temperature and 
followed by TLC. Then 1 M HCl was added until the pH of the solution became neutral or 
slightly acidic. The organic layers were collected and washed with brine (2 x 20 mL), dried over 
MgSO4 and concentrated in vacuum. The crude product was purified by column chromatography 
(7:3 Pentane/Ethyl acetate) to afford the pure compound 22 (2.8 g, 12 mmol, 96% yield) as a 
yellow resin. 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 9.1 Hz, 1H, ArH), 6.94 – 6.89 (m, 2H, ArH), 
4.29 (dd, 1H, J = 7.2, 0.9 Hz, CH2CH3), 4.25 (dd, 1H, J = 7.2, 0.8 Hz, CH2CH3), 3.89 (s, 3H, 
OMe), 3.70 (dd, J = 8.2, 3.9 Hz, 1H, CH), 3.50 (ddt, J = 17.2, 4.0, 1.0 Hz, 1H, CH2), 3.33 (dd, 1 
H, J = 17.3, 8.1 Hz, CH2), 1.31 (t, J = 7.1 Hz, 3H, CH2CH3).  
The characterization data for compounds 22 is corresponding to the reported values.13 
2-(((tert-Butyldiphenylsilyl)oxy)methyl)prop-2-en-1-ol (24) 
 
Following a reported procedure,14 2-methylenepropane-1,3-diol 23 (0.50 mL, 6.1 mmol) was 
dissolved in THF (15 mL), the solution was cooled at 0 °C before the addition of NaH (0.25 g 
60% dispersed in mineral oil, 6.1 mmol, 1.0 equiv.). After 1 h, TBDPSCl (1.6 mL, 6.1 mmol, 1.0 
equiv.) was added and the reaction was stirred at room temperature for 18-20 h. The solution was 
then cooled to 0 °C and quenched with iced water and then extracted with diethyl ether (3 x 50 
mL). The organic layers are recombined and washed with a saturated solution of K2CO3 (50 mL), 
brine (50 mL) and dried over Na2SO4. Evaporation of the solvent afforded compound 24 (2.0 g, 
6.1 mmol, 99% yield) as a colorless oil which was used without further purification for the 
transesterification. 
1H NMR (400 MHz, Chloroform-d) δ 7.82 – 7.62 (m, 4H, Ph), 7.52 – 7.30 (m, 6H, Ph), 5.16 (s, 
1H, CCH2), 5.12 (s, 1H, CCH2), 4.26 (s, 2H, CH2C), 4.20 – 4.16 (m, 2H, CH2C), 1.08 (s, 9H, 
tBu). 
 
The characterization data for compounds 24 is corresponding to reported values.14 
                                                 
13 A. Martinez, M. Fernandez, J. Estevez, J.R. Estevez, L. Castaldo, Tetrahedron Lett. 2005, 61, 1353. 
14 F. Russo, F. Wangsell, J. Saevmarker, M. Jacobsson, M. Larhed, Tetrahedron 2009, 65, 10047. 
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2-(((tert-Butyldiphenylsilyl)oxy)methyl)allyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1k) 
 
Substrate 1k was synthetized following a reported procedure,13 in a 2 neck 50 mL flask 
compound 22 (0.30 g, 1.3 mmol) DMAP (0.16 g, 1.3 mmol, 1.0 equiv.), 2-((tert-
butyldiphenylsilyl)methyl)prop-2-en-1-ol (24) (0.44 g, 1.4 mmol, 1.1 equiv.) and c.a 200-300 mg 
of activated 5Å MS were suspended in dry toluene (6.5 mL, 0.2 M) and the reaction mixture 
heated to reflux till disappearance of the starting material (TLC Pentane:Ethyl Acetate 4:1). The 
reaction was quenched with 1 M HCl and water; the aqueous layer was extracted with diethyl 
ether (2 x 30 mL). The organic layers were collected and washed with NaHCO3 and brine and 
then dried over MgSO4. Filtration and removal of the solvent under reduced pressure afforded the 
crude product which was purified by column chromatography (Pentane:Ethyl Acetate 4:1). The 
title compound 1k (0.28 g, 0.53 mmol, 42% yield) was obtained as a colorless oil  
1H NMR (400 MHz, Chloroform-d) δ 7.71 – 7.64 (m, 4H, Ph+ ArH), 7.46 – 7.33 (m, 7H, Ph), 
6.91 (ddd, J = 8.6, 1.9, 1.1 Hz, 1H, ArH), 6.90 – 6.88 (m, 1H, ArH), 5.30 (s, 1H, CMeCH2), 5.22 
(s, 1H, CMeCH2), 4.77 – 4.67 (m, 2H, CH2CMe), 4.21 (dt, J = 2.2, 1.4 Hz, 2H, CH2OTBDPS), 
3.89 (s, 3H, OMe), 3.68 (dd, J = 8.2, 4.0 Hz, 1H, CH), 3.44 (dd, J = 17.3, 4.1 Hz, 1H, CH2), 3.33 
– 3.21 (m, 1H, CH2), 1.05 (s, 9H, tBu). 
13C NMR (101 MHz, Chloroform-d) δ 197.2, 169.0, 165.9, 156.6, 142.3, 135.5, 133.4, 129.7, 
128.5, 127.7, 126.4, 115.9, 113.1, 109.6, 65.6, 64.5, 55.8, 53.4, 30.3, 26.8, 19.3. 
IR νmax 2956 (w), 2932 (w), 2858 (w), 1744 (w), 1743 (w), 1709 (s), 1600 (s), 1261 (s), 1111 (s), 
1090 (m). 
The characterization data is corresponding to the reported values.6 
 
2-Phenylprop-2-en-1-ol (26) 
 
Following a reported procedure,15 phenylmagnesium bromide (69 mL, 90 mmol, 3 equiv.) was 
added dropwise to a cooled (-78 °C) mixture of prop-2-yn-1-ol (25) (1.2 ml, 30 mmol) and 
copper(I) iodide (2.86 g, 15.0 mmol, 0.5 equiv.) in THF (40.0 mL). The resultant reaction 
                                                 
15S. M. Smith, G.L. Hoang, R. Pal, M. O. B. Khaled, L. S. Pelter, X.C. Zeng, J. M. Takacs, Chem. Commun., 2012, 
48, 12180. 
S17 
 
mixture was allowed to slowly warm to room temperature and stirred for 16 h. The reaction 
mixture was then cooled to 0 °C and quenched with sat. ammonium chloride (20 mL) and then 
extracted with diethyl ether (3 x 30 mL). The combined organic extracts were dried over 
anhydrous Na2SO4 and then concentrated under reduced pressure. Flash chromatography over 
silica gel (Hexane:EtOAc 80:20) afforded the desired compound 26 (3.1 g, 23 mmol, 77% yield) 
as a colorless oil.  
 
RF 0.4 (Hexanes:Ethyl Acetate 75:25). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.55–7.45 (m, 2H, Ph), 7.45– 7.30 (m, 3H, Ph), 5.50 (s, 
1H, CCH2), 5.39 (s, 1H, CCH2), 4.55 (s, 2H, CH2C), 2.28 (br, 1H, OH). 
 
The characterization data for compounds 26 corresponded to the reported values.15 
 
 
2-Phenylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1l) 
 
 
 
Substrate 1l was synthetized following a reported procedure,13 in a 2 neck 25 mL flask compound 
22 (0.368 g, 2.00 mmol), DMAP (0.244 g, 2.00 mmol, 1.0 equiv.), 2-phenylprop-2-en-1-ol (26) 
(0.282 g, 2.10 mmol, 2.1 equiv.) and c.a 200-300 mg of activated 5Å MS were suspended in 
toluene (11.0 mL) and the reaction mixture heated to reflux until disappearance of the starting 
material (TLC Pentane:Ethyl Acetate 4:1). The reaction was quenched with 1 M HCl and water; 
the aqueous layer was extracted with diethyl ether (2 x 30 mL). The organic layers were collected 
and washed with NaHCO3 and brine and then dried over MgSO4. Filtration and removal of the 
solvent under reduced pressure afforded the title compound 1l (0.121 g, 0.375 mmol, 19 % yield) 
that was obtained as a colorless oil used without further purification in the following step. 
 
RF 0.2 (Pentane:Ethyl Acetate 2:1) 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 8.5 Hz, 1H, ArH), 7.48 – 7.40 (m, 2H, Ph), 
7.39 – 7.28 (m, 3H, Ph), 6.95 – 6.85 (m, 2H, ArH), 5.55 (s, 1H, CPhCH2), 5.44 (s, 1H, CPhCH2), 
5.15 – 5.01 (m, 2H, CH2CPh), 3.89 (s, 3H, OMe), 3.74 (dd, J = 8.2, 3.9 Hz, 1H, CH), 3.44 (dd, J 
= 17.3, 3.9 Hz, 1H, CH2), 3.28 (dd, J = 17.3, 8.2 Hz, 1H, CH2).
16 
13C NMR (101 MHz, Chloroform-d) δ 197.4, 169.3, 166.0, 156.7, 142.2, 138.1, 128.6, 128.2, 
126.5, 126.2, 116.1, 115.4, 112.7, 109.7, 66.7, 55.9, 53.6, 30.4. 
IR νmax 3060 (w), 2941 (w), 2842 (w), 1741 (m), 1705 (s), 1600 (s), 1493 (w), 1307 (w), 1262 
(s), 1156 (w), 1091 (m), 1027 (w) 
                                                 
16 The compound was used in the next step without further purifications, compound 5l was obtained in a 1:0.78 ratio 
mixture with compound 30.  
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HRMS (ESI) calcd for C20H19O4
+ [M+H]+ 323.1278; found 323.1276. 
 
2-Chloroallyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1m)  
 
Substrate 1m was synthetized following a reported procedure,17 in a 2-neck 50 mL flask 
compound 22 (0.71 g, 3.0 mmol), DMAP (0.37 g, 3.0 mmol, 1.0 equiv.), 2-chloroprop-2-en-1-ol 
(0.29 g, 3.2 mmol, 1.05 equiv.) and c.a 200-300 mg of activated 5Å MS were suspended in 
toluene (11.0 mL) and the reaction mixture heated to reflux till disappearance of the starting 
material (TLC 9:1, Pentane:Ethyl Acetate). The reaction was quenched with 1 M HCl and water; 
the aqueous layer was extracted with diethyl ether (2x 30 mL). The organic layers were collected, 
washed with NaHCO3, brine, dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude is purified by column chromatography: 1:1 DCM:Pentane, 4:1 DCM/Pentane 
and then 100% DCM. The title compound 1m (0.49 g, 1.8 mmol, 58% yield) was obtained as 
yellow oil. 
1H NMR (400 MHz, Chloroform-d) δ 7.69 (d, J = 9.2 Hz, 1H, ArH), 6.99 – 6.83 (m, 2H, ArH), 
5.58 (q, J = 1.5 Hz, 1H, CClCH2), 5.40 (dt, J = 1.9, 0.8 Hz, 1H, CClCH2), 4.86 – 4.63 (m, 2H, 
CH2CCl), 3.89 (s, 3H, OMe), 3.77 (dd, J = 8.2, 4.0 Hz, 1H, CH), 3.52 (dd, J = 17.4, 4.0 Hz, 1H, 
CH2), 3.33 (dd, J = 17.3, 8.2 Hz, 1H, CH2). 
 
13C NMR (101 MHz, Chloroform-d) δ 197.0, 168.5, 166.0, 156.6, 135.1, 128.3, 126.4, 116.1, 
114.8, 109.6, 66.4, 55.8, 53.3, 30.2. 
 
IR νmax 2944 (w), 2843 (w), 1746 (m), 1705 (s), 1599 (s), 1491 (w), 1337 (w), 1306 (m), 1259 
(s), 1190 (w), 1144 (m), 1105 (m), 1089 (m), 1026 (w), 987 (w). 
 
4. General procedures for the synthesis of α-substituted allyl β-keto esters. 
General procedure GP2 for the synthesis of α-azido allyl β-keto esters. 
In an open flask allyl β-keto ester 1 in toluene (1 M) is stirred for 1-2 minutes before the addition 
in one portion of the hypervalent iodine reagent 2 (1.3 equiv.). The reaction was stirred at room 
temperature till disappearance of the starting material by TLC. Upon completion the reaction was 
directly purified by flash chromatography in 100% pentane and then following the polarity of the 
RF indicated for each compound. 
                                                 
17 J. Hierold, D. W. Lupton, Org. Lett. 2012, 14, 3412. 
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Figure S1. Scope of the α-azidation of β-allyl keto esters with hypervalent iodine reagents. 
Allyl 2-azido-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4a) 
 
Following general procedure GP2, starting from 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1a) (0.52 g, 2.1 mmol), allyl 2-azido-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (4a) (0.470 g, 1.65 mmol, 78% yield) was obtained as a brown solid 
RF 0.3 (Pentane:Ethyl Acetate 9:1).  
Mp = 55-57°C 
1H NMR (400 MHz, Chloroform-d) δ 7.68 (d, J = 8.6 Hz, 1H, ArH), 6.92 (dd, J = 8.6, 2.3 Hz, 
1H, ArH), 6.86 (d, J = 2.4 Hz, 1H, ArH), 5.80 (m, J = 17.2, 10.5, 5.6 Hz, 1H, CHCH2), 5.28 – 
5.09 (m, 2H, CHCH2), 4.72 – 4.57 (m, 2H, CH2CH), 3.86 (s, 3H, OMe), 3.59 (d, J = 17.4 Hz, 1H, 
CH2), 2.93 (dd, J = 17.4, 0.9 Hz, 1H, CH2). 
13C NMR (101 MHz, Chloroform-d) δ 195.2, 168.4, 166.8, 155.3, 130.9, 127.3, 125.9, 119.0, 
116.7, 109.6, 70.5, 66.9, 55.9, 38.4. 
IR νmax 3080 (w), 2944 (w), 2844 (w), 2108 (s), 1747 (m), 1711 (s), 1599 (s), 1307 (w), 1264 (s), 
1231 (s), 1184 (m), 1152 (w), 1091 (m), 1045 (m), 1026 (m), 929 (w). 
HRMS (ESI) calcd for C14H13N3NaO4
+ [M+Na]+ 310.0798; found 310.0795. 
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2-Methylallyl 2-azido-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4b) 
 
Following general procedure GP2, starting from 2-methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1b) (1.0 g, 3.9 mmol, 2-methylallyl 2-azido-5-methoxy-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (4b) (1.1 g, 3.8 mmol, 96% yield) was obtained as a yellow 
solid. 
RF 0.35 (Pentane:Ethyl Acetate 4:1).  
Mp: 41-44°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.76 (d, J = 8.6 Hz, 1H, ArH), 6.97 (dd, J = 8.6, 2.2 Hz, 
1H, ArH), 6.88 (d, J = 2.3 Hz, 1H, ArH), 4.91 (s, 2H, CCH2), 4.63 (s, 2H, CH2CMe), 3.91 (s, 3H, 
OMe), 3.64 (d, J = 17.3 Hz, 1H, CH2), 2.99 (d, J = 17.3 Hz, 1H, CH2), 1.69 (d, J = 1.2 Hz, 3H, 
CH3). 
13C NMR (101 MHz, Chloroform-d) δ 195.2, 168.5, 166.7, 155.2, 138.8, 127.4, 126.1, 116.6, 
113.9, 109.6, 70.6, 69.7, 55.9, 38.5, 19.3. 
IR νmax 2108 (m), 1748 (m), 1710 (m), 1599 (s), 1493 (w), 1448 (w), 1342 (w), 1306 (w), 1265 
(s), 1230 (m), 1184 (m), 1148 (w), 1092 (w), 1024 (w), 982 (w), 909 (w), 850 (w), 737 (w). 
HRMS (ESI) calcd for C15H15N3NaO4
+ [M+Na]+ 324.0955; found 324.0961. 
2-Methylallyl 2-azido-5-methyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4c) 
Following general procedure GP2, starting from 2-methylallyl 5-methyl-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1c) (0.158 g, 0.647 mmol), 2-methylallyl 2-azido-5-methyl-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (4c) (0.162 g, 0.568 mmol, 88% yield) was obtained as a 
yellow solid. 
RF 0.52 (Pentane:Ethyl Acetate 4:1).  
Mp: 36-39°C. 
1H NMR (400 MHz, Chloroform-d) δ 7.24 – 7.20 (m, 1H, ArH), 6.79 – 6.72 (m, 2H, ArH), 4.40 
(s, 2H, CMeCH2), 4.12 (s, 2H, CH2CMe), 3.15 (d, J = 17.3 Hz, 1H, CH2), 2.50 (d, J = 17.3 Hz, 
1H, CH2), 1.97 (s, 3H, ArCH3), 1.18 (s, 3H, CH3). 
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13C NMR (101 MHz, Chloroform-d) δ 196.7, 168.3, 152.5, 148.2, 138.8, 130.8, 129.8, 126.8, 
125.4, 113.9, 70.5, 69.7, 38.4, 22.3, 19.3. 
IR νmax 2974 (w), 2973 (w), 2938 (w), 2938 (w), 2109 (s), 2108 (s), 1748 (s), 1716 (s), 1609 (m), 
1270 (s), 1225 (s), 1181 (s), 1045 (m), 908 (m), 754 (m), 744 (m), 737 (m). 
HRMS (APPI) calcd for C15H16NO3
+ [M-N2]
+ 258.1125; found 258.1126 
2-Methylallyl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4d) 
Following general procedure GP2, starting from 2-methylallyl 1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1d) (0.25 g, 1.1 mmol), 2-methylallyl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (4d) (0.10 g, 1.1 mmol, >99% yield) was obtained as a yellow oil  
RF 0.33 (Dichloromethane:Pentane 5:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.84 (dt, J = 7.7, 1.0 Hz, 1H, ArH), 7.68 (dd, J = 7.6, 1.2 
Hz, 1H, ArH), 7.53 – 7.40 (m, 2H, ArH), 4.93 – 4.84 (m, 2H, C CH2), 4.62 (s, 2H, CH2C), 3.70 
(d, J = 17.3 Hz, 1H, CH2), 3.06 (d, J = 17.3 Hz, 1H, CH2), 1.67 (s, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 197.4, 168.2, 152.0, 138.7, 136.5, 133.1, 128.5, 126.4, 
125.6, 114.0, 70.3, 69.8, 38.6, 19.3. 
IR νmax 3057 (w), 2985 (w), 2114 (w), 1750 (w), 1723 (w), 1266 (m), 1228 (w), 1185 (w), 738 
(s). 
HRMS (ESI) calcd for C14H14NO3
+ [M-N2+H]
+ 244.0968; found 244.0957. 
.2-Methylallyl 2-azido-5-bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4e) 
Following general procedure GP2, starting from 2-methylallyl 5-bromo-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1e) (0.11 g, 0.36 mmol), 2-methylallyl 2-azido-5-bromo-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (4e) (0.10 g, 0.29 mmol, 80 % yield) was obtained as a yellow 
solid. 
 
RF 0.52 (Pentane:Ethyl Acetate 9:1).  
 
Mp: 71-73°C. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.69 (d, J = 8.2 Hz, 1H, ArH), 7.66 (d, J = 1.3 Hz, 1H, 
ArH), 7.60 (dd, J = 8.2, 1.5 Hz, 1H, ArH), 4.92 (s, 1H, CCH2), 4.90 (s, 1H, CCH2), 4.63 (s, 2H, 
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CH2CMe), 3.67 (d, J = 17.5 Hz, 1H, CH2), 3.03 (d, J = 17.5 Hz, 1H, CH2), 1.69 (t, J = 1.1 Hz, 
3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 196.3, 167.8, 153.4, 138.6, 132.2, 132.2, 131.9, 129.8, 
126.7, 114.2, 70.2, 70.0, 38.2, 19.3. 
 
IR νmax 2946 (w), 2919 (w), 2114 (s), 1752 (s), 1726 (s), 1681 (w), 1597 (m), 1264 (s), 1230 (s), 
1183 (m), 911 (m), 910 (m). 
 
HRMS (APPI) calcd for C14H13
79BrN3O3
+ [M+H]+ 349.0062; found [M-N2+H]
+ 322.0072. 
 
2-Methylallyl 2-azido-6-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4f) 
Following general procedure GP2, starting from 2-methylallyl 6-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1f) (0.15 g, 0.58 mmol), 2-methylallyl 2-azido-6-methoxy-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (4f) (0.12 g, 0.41 mmol, 70% yield) was obtained as yellow 
solid. 
RF 0.85 (Pentane:Ethyl Acetate 4:1).  
Mp: 50-53°C 
1H NMR (400 MHz, Chloroform-d) 7.36 (d, J = 8.4 Hz, 1H, ArH), 7.27 (dd, J = 8.4, 2.6 Hz, 
1H, ArH), 7.23 (d, J = 2.5 Hz, 1H, ArH), 4.90 (m, 2H, CMeCH2), 4.62 (s, 2H, CH2CMe), 3.85 (s, 
3H, OMe), 3.62 (d, J = 17.0 Hz, 1H, CH2), 2.98 (d, J = 16.9 Hz, 1H, CH2), 1.68 (t, J = 1.2 Hz, 
3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 197.3, 168.2, 160.1, 145.0, 138.7, 134.2, 127.1, 126.0, 
113.9, 106.4, 71.0, 69.7, 55.7, 38.0, 19.3. 
IR νmax 3081 (w), 2943 (w), 2841 (w), 2112 (s), 1748 (s), 1718 (s), 1494 (m), 1302 (m), 1275 (s), 
1228 (s), 1180 (s), 1029 (m). 
HRMS (APPI) calcd for C15H16N3O4
+ [M+H]+ 302.1135; found 302.1136. 
 
2-Methylallyl 2-azido-6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4g) 
Following general procedure GP2, starting from 2-methylallyl 6-chloro-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1g) (0.167 g, 0.631 mmol), 2-methylallyl 2-azido-6-chloro-1-oxo-2,3-
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dihydro-1H-indene-2-carboxylate (4g) (0.154 g, 0.504 mmol, 80% yield) was obtained as a dark 
brown oil. 
RF 0.4 (Dichloromethane:Pentane 1:1).  
 
1H NMR (400 MHz, Chloroform-d) 7.79 (d, J = 2.0 Hz, 1H, ArH), 7.64 (dd, J = 8.2, 2.1 Hz, 
1H, ArH), 7.42 (dd, J = 8.2, 0.8 Hz, 1H, ArH), 4.92 (m, 1H, CMeCH2), 4.63 (s, 2H, CH2CMe), 
3.66 (d, J = 17.6 Hz, 1H, CH2), 3.02 (dd, J = 17.4, 0.9 Hz, 1H, CH2), 1.78 – 1.60 (m, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 196.3, 167.8, 150.1, 138.6, 136.5, 134.9, 134.6, 127.6, 
125.2, 114.2, 70.7, 70.0, 38.2, 19.3. 
 
IR νmax 3086 (w), 2954 (w), 2941 (w), 2114 (s), 1752 (s), 1724 (s), 1469 (w), 1429 (m), 1252 (s), 
1227 (s), 1197 (s), 1185 (s), 1110 (w), 1047 (m), 910 (m), 826 (w), 714 (m). 
 
HRMS (ESI) calcd for C14H13ClNO3
+ [M+H]+ 278.0578; found 278.0581. 
2-Methylallyl 2-azido-1-oxo-6-(trifluoromethyl)-2,3-dihydro-1H-indene-2-carboxylate (4h) 
 
Following general procedure GP2, starting from 2-methylallyl 1-oxo-6-(trifluoromethyl)-2,3-
dihydro-1H-indene-2-carboxylate (1h) (0.25 g, 0.83 mmol), 2-methylallyl 2-azido-1-oxo-6-
(trifluoromethyl)-2,3-dihydro-1H-indene-2-carboxylate (4h) (0.20 g, 0.60 mmol, 72% yield) was 
obtained as dark brown oil.  
RF 0.35 (Pentane:Ethyl Acetate 9:1).  
 
1H NMR (400 MHz, Chloroform-d) δ 8.08 (s, 1H, ArH), 7.93 (dd, J = 8.1, 1.7 Hz, 1H, ArH), 
7.64 (d, J = 8.1 Hz, 1H, ArH), 4.93 (t, J = 1.4 Hz, 1H, CMeCH2), 4.90 (q, J = 1.2 Hz, 1H, 
CMeCH2), 4.63 (s, 2H, CH2CMe), 3.76 (d, J = 17.8 Hz, 1H, CH2), 3.12 (d, J = 17.7 Hz, 1H, 
CH2), 1.67 (t, J = 1.1 Hz, 3H, CH3). 
 
13C NMR (101 MHz, CDCl3) δ 196.4 , 167.6 , 155.1 , 138.5 , 133.5 , 132.8 (d, J = 3.5 Hz), 
131.4 (q, J = 33.5 Hz), 127.3 , 123.5 (q, J = 272.9 Hz), 122.8 (q, J = 4.0 Hz), 114.3 , 70.4 , 70.1 , 
38.6 , 19.3 . 
 
19F NMR (376 MHz, CDCl3) δ -62.7. 
 
IR νmax 2982 (w), 2945 (w), 2116 (m), 1752 (m), 1729 (m), 1626 (w), 1332 (s), 1254 (s), 1228 
(m), 1173 (s), 1131 (s), 1054 (m), 912 (m). 
 
HRMS (ESI) calcd for C15H12F3N3NaO3
+ [M+Na] + 362.0728; found 362.0731. 
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2-Methylallyl 2-azido-6-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4i) 
Following general procedure GP2, starting from 2-methylallyl 6-fluoro-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1i) (0.20 g, 0.80 mmol), 2-methylallyl 2-azido-6-fluoro-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (4i) (0.21 g, 0.75 mmol, 93% yield) was obtained as a yellow 
oil. 
RF 0.3 (Dichloromethane:Pentane 5:1). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.52 – 7.35 (m, 3H, ArH), 4.91 (m, 1H, CCH2), 4.89 (m, 
1H, CCH2), 4.63 (s, 2H, CH2CMe) 3.66 (dt, J = 17.1, 1.1 Hz, 1H, CH2), 3.02 (dt, J = 17.2, 1.3 
Hz, 1H, CH2), 1.68 (t, J = 1.1 Hz, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 196.6, 167.8, 162.7 (d, J = 250.1 Hz), 147.5 (d, J = 2.4 
Hz), 138.6, 134.8 (d, J = 7.7 Hz), 127.9 (d, J = 8.0 Hz), 124.3 (d, J = 23.7 Hz), 114.1, 111.34 (d, 
J = 22.4 Hz), 71.0, 70.0, 38.1, 19.3.  
 
IR νmax 3081 (w), 2982 (w), 2945 (w), 2114 (s), 1750 (s), 1726 (s), 1490 (m), 1440 (w), 1331 
(m), 1259 (s), 1226 (s), 1180 (s), 1132 (s), 1051 (m), 912 (m). 
 
HRMS (ESI) calcd for C14H13FN3O3
+ [M+H]+ 290.0935; found 290.1006. 
2-Methylallyl 2-azido-4-bromo-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (4j) 
Following general procedure GP2, starting from 2-methylallyl 4-bromo-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1j) (0.11 g, 0.37 mmol), 2-methylallyl 2-azido-4-bromo-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (4j) (0.11 g, 0.33 mmol, 90% yield) was obtained as a colorless 
oil. 
 
RF 0.32 (Pentane:Ethyl Acetate 9:1).  
 
1H NMR (400 MHz, Chloroform-d) δ 7.84 (dd, J = 7.8, 1.0 Hz, 1H, ArH), 7.78 (dd, J = 7.7, 0.9 
Hz, 1H, ArH), 7.36 (t, J = 7.7 Hz, 1H, ArH), 4.92 (s, 1H, CMeCH2), 4.90 (s, 1H, CMeCH2), 4.64 
(s, 2H, CH2CMe), 3.62 (d, J = 17.8 Hz, 1H, CH2), 2.98 (d, J = 17.8 Hz, 1H, CH2), 1.68 (s, 3H, 
CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 196.8, 167.7, 151.7, 139.2, 138.6, 135.0, 130.2, 124.4, 
121.7, 114.2, 70.1, 70.0, 39.7, 19.3. 
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IR νmax 2116 (s), 1754 (s), 1727 (s), 1261 (s), 1227 (s), 1184 (w), 1111 (w), 1045 (w), 918 (w), 
776 (w), 716 (w). 
 
HRMS (APPI) calcd for C14H12BrN3NaO3
+ [M+Na] + 371.9960; found 371.9962. 
 
2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl 2-azido-5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (4k) 
 
Following general procedure GP2, starting from 2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl 5-
methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1k) (0.17 g, 0.34 mmol), 2-(((tert-
butyldiphenylsilyl)oxy)methyl)allyl 2-azido-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (4k) (0.17 g, 0.31 mmol, 92% yield) was obtained as a yellow oil. 
RF 0.3 (Pentane: Ethyl Acetate 9:1).  
 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 8.6 Hz, 1H, ArH), 7.65 – 7.59 (m, 4H, Ph), 
7.47 – 7.33 (m, 6H, Ph), 6.93 (dd, J = 8.6, 2.2 Hz, 1H, ArH), 6.81 – 6.77 (m, 1H, ArH), 5.27 – 
5.24 (m, 1H, CCH2), 5.09 (q, J = 1.3 Hz, 1H, CCH2), 4.79 (dd, J = 13.0, 0.7 Hz, 1H, CH2CCH2), 
4.71 (dd, J = 13.1, 0.6 Hz, 1H, CH2CCH2), 4.17 – 4.03 (m, 2H, CCH2OTBDPS), 3.88 (s, 3H, 
OMe), 3.53 (dd, J = 17.4, 0.9 Hz, 1H, CH2), 2.92 (d, J = 17.6 Hz, 1H, CH2), 1.03 (s, 9H, 
tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 195.1, 168.3, 166.6, 155.1, 141.6, 135.5, 133.3, 133.2, 
129.8, 127.7, 127.4, 126.0, 116.5, 113.6, 109.5, 70.6, 66.6, 64.4, 55.9, 38.5, 26.8, 19.3.18 
 
IR νmax 3070 (w), 2960 (w), 2936 (w), 2860 (w), 2110 (m), 1749 (w), 1713 (m), 1601 (m), 1266 
(s), 1232 (w), 1181 (w), 1109 (m), 1093 (m), 910 (s), 704 (s).  
 
HRMS (ESI) calcd for C31H34NO5Si+ [M+H-N2]
+ 528.2201; found 528.2178 
 
General procedure GP3 for the synthesis of α-cyano allyl β-keto esters. 
 
Following a reported procedure GP3, in an open flask allyl β-keto ester 1 is stirred in DMF (0.5 
M) for 1-2 minutes before the addition in one portion of the hypervalent iodine reagent 7 (1.1 
equiv.) The reaction is stirred at room temperature till disappearance of the starting material by 
TLC. Upon completion the reaction is directly purified by flash chromatography in 100% pentane 
and then following the solvent polarity indicated for the RF of each compound. 
                                                 
18 3 C of the phenyls group of the TBDPS are not resolved. 
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Figure S2. Scope of the α-cyanation of β-allyl keto esters with hypervalent iodine reagents. 
 
 
Allyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5a) 
 
Following general procedure GP3, starting from allyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (1a) (0.500 g, 2.03 mmol), allyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-indene-
2-carboxylate (5a) (0.518 g, 1.91 mmol, 94% yield) was obtained as a light yellow oil. 
RF 0.30 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d) δ  7.78 (d, J = 8.6 Hz, 1H, ArH), 7.00 (dd, J = 8.6, 2.2 Hz, 
1H, ArH), 6.94 (d, J = 2.2 Hz, 1H, ArH), 5.92 (ddt, J = 17.0, 10.5, 5.6 Hz, 1H, CHCH2), 5.40 
(dd, J = 17.0, 1.2 Hz, 1H, CCH2), 5.30 (dd, J = 10.5, 1.2 Hz, 1H, CCH2), 4.75 (dd, J = 5.6, 1.2 
Hz, 2H, CH2CH ), 3.93 (s, 3H, OMe), 3.89 (d, J = 17.3 Hz, 1H, CH2), 3.63 (d, J = 17.3 Hz, 1H, 
CH2). 
13C NMR (101.00 MHz, Chloroform-d) δ 188.5, 167.2, 164.2, 154.9, 130.5, 128.2, 125.1, 
119.8, 117.4, 116.5, 109.7, 68.2, 56.1, 54.7, 37.6. 
IR νmax  3017 (w), 2949 (w), 2844 (w), 2249 (w), 1750 (m), 1722 (s), 1601 (s), 1494 (w), 1311 
(m), 1269 (s), 1093 (m). 
HRMS (ESI) calcd for C15H14NO4
+ [M+H]+ 272.0917; found 272.0927. 
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2-Methylallyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5b) 
 
 
 
Following general procedure GP3, starting from 2-methylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1b) (1.0 g, 3.8 mmol), 2-methylallyl 2-cyano-5-methoxy-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (5b) (0.981 g, 3.44 mmol, 90% yield) was obtained as a yellow 
resin.  
RF 0.25 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 8.6 Hz, 1H, ArH), 6.93 (dd, J = 8.6, 1.9 Hz, 
1H, ArH), 6.89 – 6.85 (m, 1H, ArH), 4.98 – 4.95 (s, 1H, CCH2), 4.92 – 4.89 (s, 1H, CCH2), 4.64 
– 4.54 (m, 2H, CH2CMe), 3.86 (s, 3H, OMe), 3.83 (d, J = 17.2 Hz, 1H, CH2), 3.56 (d, J = 17.2 
Hz, 1H, CH2), 1.70 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 188.5, 167.2, 164.2, 154.9, 138.5, 128.2, 125.1, 
117.4, 116.2, 114.5, 109.6, 70.9, 56.2, 54.8, 37.5, 19.4. 
IR νmax 2983 (w), 2946 (w), 2844 (w), 2250 (w), 1751 (m), 1725 (s), 1600 (s), 1451 (w), 1268 
(s), 1209 (m), 1093 (m). 
HRMS (ESI) calcd for C16H16NO4
+ [M+H]+ 286.1074; found 286.1085. 
 
2-Methylallyl 2-cyano-5-methyl-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5c) 
 
Following general procedure GP3, starting from 2-methylallyl 5-methyl-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1c) (0.195 g, 0.800 mmol), 2-methylallyl 2-cyano-5-methyl-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (5c) (0.204 g, 0.758 mmol, 95% yield) was obtained as a 
yellow oil.  
RF 0.3 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.74 (d, J = 8.0 Hz, 1H, ArH), 7.34 (s, 1H, ArH), 7.30 (d, 
J = 8.0 Hz, 1H, ArH), 5.03 (s, 1H, CCH2), 4.97 (s, 1H, CCH2), 4.66 (m, 2H, CH2CMe ), 3.90 (d, 
J = 17.2 Hz, 1H, CH2), 3.64 (d, J = 17.2 Hz, 1H, CH2), 2.49 (s, 3H, CH3), 1.77 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ  190.0, 164.1, 152.2, 149.1, 138.5, 130.5, 129.9, 
126.9, 126.3, 116.0, 114.5, 70.9, 54.7, 37.5, 22.5, 19.4. 
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IR νmax  2983 (w), 2944 (w), 2865 (w), 2248 (w), 1731 (s), 1609 (m), 1452 (w), 1266 (m), 1207 
(m), 905 (w). 
HRMS (ESI) calcd for C16H15NNaO3
+ [M+Na]+ 292.0944; found 292.0951. 
 
2-Methylallyl 2-cyano-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5d) 
 
Following general procedure GP3, starting from 2-methylallyl 1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1d) (0.184 g, 0.800 mmol), 2-methylallyl 2-cyano-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (5d) (0.201 g, 0.787 mmol, 98% yield) was obtained as a pale yellow oil.  
RF 0.2 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.86 (d, J = 7.9 Hz, 1H, ArH), 7.74 (td, J = 7.5, 1.2 Hz, 
1H, ArH), 7.58 – 7.47 (m, 2H, ArH), 5.02 (s, 1H, CCH2), 4.98 (s, 1H, CCH2), 4.73 – 4.62 (m, 
2H, CH2CMe), 3.96 (d, J = 17.2 Hz, 1H, CH2), 3.71 (d, J = 17.3 Hz, 1H, CH2), 1.76 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 190.7, 163.9, 151.6, 138.4, 137.2, 132.3, 129.2, 126.6, 
126.5, 115.8, 114.6, 71.0, 54.5, 37.7, 19.4. 
IR νmax  3082 (w), 2983 (w), 2945 (w), 2250 (w), 1733 (s), 1603 (w), 1466 (w), 1436 (w), 1263 
(m), 1205 (m), 909 (m). 
HRMS (ESI) HRMS (ESI) calcd for C15H13NNaO3
+ [M+Na]+ 278.0788; found 278.0791. 
 
2-Methylallyl 5-bromo-2-cyano-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5e) 
 
 
 
Following general procedure GP3, starting from 2-methylallyl 5-bromo-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1e) (0.200 g, 0.647 mmol), 2-methylallyl 5-bromo-2-cyano-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (5e) (0.190 g, 0.569 mmol, 88% yield) was obtained as an 
orange oil.  
RF 0.7 (Pentane:Ethyl Acetate 9:1).  
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1H NMR (400 MHz, Chloroform-d) δ 7.76 – 7.68 (m, 2H, ArH ), 7.67 – 7.62 (m, 1H, ArH), 
5.03 (s, 1H, CCH2), 4.99 (s, 1H, CCH2), 4.66 (s, 2H, CH2CMe), 3.94 (d, J = 17.4 Hz, 1H, CH2), 
3.68 (d, J = 17.5 Hz, 1H, CH2), 1.77 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 189.5, 163.5, 152.9, 138.3, 132.9, 131.1, 130.0, 
127.4, 115.4, 114.7, 71.2, 54.5, 37.2, 19.4. 
IR νmax  3088 (w), 2982 (w), 2943 (w), 2251 (w), 1738 (s), 1595 (m), 1424 (w), 1255 (m), 1060 
(w), 909 (m). 
HRMS (ESI) calcd for C15H13
79BrNO3
+ [M+H]+ 334.0073; found 334.0087. 
 
2-Methylallyl 2-cyano-6-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5f) 
 
Following general procedure GP3, starting from 2-methylallyl 6-fluoro-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1i) (0.199 g, 0.800 mmol), 2-methylallyl 2-cyano-6-fluoro-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (5f) (0.153 g, 0.560 mmol, 70% yield) was obtained as a 
yellow oil.  
RF 0.7 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.54 (m, 1H, ArH), 7.46 (m, 2H, ArH), 4.99 (s, 1H, 
CCH2), 4.96 (s, 1H, CCH2), 4.64 (s, 2H, CH2CMe), 3.91 (d, J = 17.1, 1H, CH2), 3.67 (d, J = 17.1, 
1H, CH2), 1.74 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 189.9, 163.4, 162.9 (d, J = 251.2 Hz), 147.2 (d, J = 
1.9 Hz), 138.2, 133.9 (d, J = 8.1 Hz), 128.2 (d, J = 8.1 Hz), 125.0 (d, J = 23.9 Hz), 115.3, 114.5, 
111.9 (d, J = 22.8 Hz), 70.9, 55.2, 37.0, 19.2. 
IR νmax 3089 (w), 2942 (w), 2869 (w), 2251 (w), 1737 (s), 1600 (w), 1491 (m), 1440 (m), 1298 
(m), 1267 (s), 1205 (m). 
HRMS (ESI) calcd for C15H12FNNaO3
+ [M+Na]+ 296.0693; found 296.0696. 
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2-(((Tert-butyldiphenylsilyl)oxy)methyl)allyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (5g) 
 
Following general procedure GP3, starting from 2- (((tert-butyldiphenylsilyl)oxy)methyl)allyl 5-
methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1k) (0.412 g, 0.800 mmol), 2-(((Tert-
butyldiphenylsilyl)oxy)methyl)allyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (5g) (0.17 g, 0.32 mmol, 40% yield) was obtained as a yellow oil.  
RF 0.5 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 8.6 Hz, 1H, ArH), 7.68 – 7.62 (m, 4H, ArH), 
7.40 (m, 6H, ArH), 6.98 (dd, J = 8.6, 2.1 Hz, 1H, ArH), 6.89 (m, 1H, ArH), 5.28 (s, 1H, CCH2), 
5.21 (s, 1H, CCH2), 4.80 (m, 2H, CH2CCH2), 4.19 (m, 2H, CH2CCH2), 3.92 (s, 3H, OMe), 3.82 
(d, J = 17.3 Hz, 1H, CH2), 3.58 (d, J = 17.3 Hz, 1H, CH2), 1.05 (s, 9H, SiC(CH3)3). 
13C NMR (101.00 MHz, Chloroform-d) δ 188.4, 167.2, 164.2, 154.8, 141.4, 135.6, 133.4, 
129.9, 127.9, 125.1, 117.4, 116.1, 114.1, 109.7, 67.6, 64.6, 56.2, 54.8, 37.5, 26.9, 19.4. 
IR νmax 3726 (w), 3708 (w), 3626 (w), 2933 (w), 2857 (w), 2361 (w), 2297 (w), 1752 (m), 1728 
(s), 1600 (s), 1429 (w), 1268 (s), 1114 (m). 
HRMS (ESI) calcd for C32H33NNaO5Si
+ [M+Na]+ 562.2020; found 562.2018. 
 
2-Phenylallyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5h) 
 
Following general procedure GP3, starting from 2-phenylallyl 5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1l) (0.258 g, 0.800 mmol), 2-phenylallyl 2-cyano-5-methoxy-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (5h) (0.139 g, 0.400 mmol, 50% yield) was obtained as a 
yellow oil.  
RF 0.5 (Pentane:Ethyl Acetate 4:1).  
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1H NMR (400 MHz, Chloroform-d) δ 7.74 (d, J = 8.7 Hz, 1H, ArH), 7.39 – 7.29 (m, 5H, ArH), 
6.98 (dd, J = 8.7, 2.2 Hz, 1H, ArH), 6.87 (d, J = 2.2 Hz, 1H, ArH), 5.55 (s, 1H, CCH2), 5.43 (s, 
1H, CCH2), 5.18 – 5.05 (m, 2H, CH2CPh), 3.92 (s, 3H, OMe), 3.66 (d, J = 17.3 Hz, 1H, CH2), 
3.50 (d, J = 16.8 Hz, 1H, CH2). 
13C NMR (101.00 MHz, Chloroform-d) δ 188.4, 167.2, 164.2, 154.8, 141.3, 137.7, 128.7, 
128.4, 126.2, 125.2, 117.4, 116.2, 116.0, 109.6, 68.7, 56.2, 54.9, 37.5. 
IR νmax 2923 (w), 2853 (w), 2249 (w), 1749 (m), 1724 (s), 1599 (s), 1494 (w), 1265 (s), 1205 
(m), 1092 (m), 908 (w). 
HRMS (ESI) calcd for C21H17NNaO4
+ [M+Na]+ 370.1050; found 370.1047 
 
2-Chloroallyl 2-cyano-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (5i) 
 
Following general procedure GP3, starting from 2-chloroallyl 5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (1m) (0.224 g, 0.798 mmol), 2-phenylallyl 2-cyano-5-methoxy-1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (5i) (0.095 g, 0.31 mmol, 39% yield) was obtained as a yellow 
oil.  
RF 0.27 (Pentane:Ethyl Acetate 4:1).  
1H NMR (400 MHz, Chloroform-d)  7.78 (d, J = 8.6 Hz, 1H, ArH), 7.01 (dd, J = 8.6, 2.3 Hz, 
1H, ArH), 6.95 (m, 1H, ArH), 5.59 (s, 1H, CCH2), 5.46 (s, 1H, CCH2), 4.80 (q, J = 13.8 Hz, 2H, 
CH2Cl), 3.94 (m, 4H, OMe + CH2), 3.66 (d, J = 17.4 Hz, 1H, CH2). 
13C NMR (101.00 MHz, Chloroform-d) δ 187.9, 167.2, 163.7, 154.7, 133.8, 128.2, 124.8, 
117.4, 115.7, 115.7, 109.6, 68.0, 56.1, 54.5, 37.4. 
IR νmax  2949 (w), 2845 (w), 2250 (w), 1756 (m), 1726 (s), 1604 (s), 1494 (w), 1449 (w), 1311 
(m), 1269 (s), 1205 (m), 1093 (m). 
HRMS (ESI) calcd for C15H13ClNO4
+ [M+H]+ 306.0528; found 306.0517. 
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5. Pd-Catalyzed decarboxylation of allyl -keto esters. 
5.1 Synthesis of Pd2(dba)3 
Pd2(dba)3 (29) 
 
Following a reported procedure,19 palladium acetate (28) (0.20 g, 0.89 mmol) was placed into a 
25 mL round-bottom flask with a magnetic stirrer. Sodium acetate (0.070 g, 0.89 mmol) was 
added followed by (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one (27) (0.420 g, 1.78 mmol) and 
MeOH (10 ml) . The reaction mixture was stirred at 40 °C for 3 h. After completion of the 
reaction a brown solid was formed. The solid was filtered off and washed with MeOH (2 x 3 mL) 
followed by water (3 x 3 mL). The residue was completely washed off the filter with CHCl3 (25 
mL), and the solution was evaporated on a rotary evaporator. The solid that formed was re-
dissolved in a minimum amount of freshly distilled chloroform (ca. 5 mL), and 20 mL of acetone 
was added to the solution. The mixture that was obtained was left overnight in a refrigerator at -
18 °C. The crystals of Pd2(dba)3·CHCl3 (29) (0.28 g, 0.31 mmol, 34% yield) were filtered off, 
washed with 2×5 mL of cold acetone (5 °C), and dried under vacuum at 40 °C.  
 
5.2 General procedure GP4 for the asymmetric decarboxylation of α-azido allyl β-
keto esters catalyzed by Pd. 
 
                                                 
19 S.S. Zalesskiy, V.P. Ananikov, Organometallics 2012, 31, 2302. 
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Substrate 4 (0.2 mmol), Pd2(dba)3 (29, 5 mol%) and ligand 6a (11 mol%) were placed in a micro 
wave vial which was sealed. The solvent THF (0.5 mL) was added and the reaction was 
immediately degased three times. The mixture was placed in a refrigerator at -20 °C and 
monitored by TLC. Upon completeness (10-15 h) the reaction was filtered through a plug of 
silica and the solvent evaporated. Purification by column chromatography yielded the product 
that was analyzed by chiral HPLC. The procedure used for optimization and scope are the same. 
Supplementary Table S1 ǀ Screening of the Solvent 
 
 
 
entry solvent NMR % Yield e.e%a 
1 THF 88 79% 
2 DCM *(0 °C) 60 63% 
3 Toluene 38 70% 
4 CH
3
CN 50 68% 
5 Et
2
O 27 71% 
6 MTBE 31 71% 
7 Me-THF 35 70% 
8 THPyran 35 70% 
9 Dioxane 38 42% 
a) Substrate 4a (0.012 mmol), Pd2(dba)3 (29  5 mol%), 6a (11 mol%) and solvent (0.2 M) at 25 °C. The ee are 
measured with chiral HPLC.  
 
 
Supplementary Table S2 ǀ Screening of the Temperature 
 
 
 
entry temperature NMR % Yield e.e%a 
1 -20°C 88 86% 
2 0°C 89 82% 
3 25°C 80 82% 
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a) Substrate 4a (0.012 mmol), Pd2(dba)3 (29 5 mol%), 6a (11 mol%) and THF (0.4 M) at 25 °C. The ee are measured 
with chiral HPLC.  
 
 
Supplementary Table S3 ǀ Screening of Ligands 
 
 
 
entry Ligand NMR % Yield e.e%a 
1 Dach 6b 10 30% 
2 Dach Naphtyl 6a 88 79% 
3 Anden 6d 15 49% 
4 DiPhenyl 6c n.r. - 
5 Stoltz 6e n.r - 
a) Substrate 10a (0.012 mmol), Pd2(dba)3 (29 5 mol%), L (11 mol%) and THF (0.4 M) at 25 °C. The ee are measured 
with chiral HPLC.  
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Supplementary Table S4 ǀ Screening of Concentrations 
 
 
 
entry Concentration NMR % Yield e.e%a 
1 0.1 M 80 82% 
2 0.2 M 88 79% 
3 0.4 M 94 82% 
a) Substrate 4a (0.012 mmol), Pd2(dba)3 (29 5 mol%), 6a (11 mol%) and THF (X M) at 25 °C. The ee are measured 
with chiral HPLC.  
 
 (R)-2-Allyl-2-azido-5-methoxy-2,3-dihydro-1H-inden-1-one (7a) 
Following general procedure GP4, starting from substrate 4a (0.057 g, 0.20 mmol), (R)-2-allyl-2-
azido-5-methoxy-2,3-dihydro-1H-inden-1-one (7a) (0.042 g, 0.17 mmol, 86% yield, 86% ee) was 
obtained as a yellow oil.  
Chiral HPLC conditions: ee: 86%.Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 15 min tR1 = 8.9 
min and tR2 = 10.5 min. λ = 280 cm-1. 
RF 0.4 (Dichloromethane:Pentane 2:1).  
1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 8.6 Hz, 1H, ArH), 6.94 (dd, J = 8.6, 2.2 Hz, 
1H, ArH), 6.83 (d, J = 2.2 Hz, 1H, ArH), 5.73 (ddt, J = 17.2, 10.1, 7.2 Hz, 1H, CHCH2), 5.29 – 
5.08 (m, 2H, CHCH2), 3.89 (s, 3H, OCH3), 3.20 (d, J = 17.5 Hz, 1H, CH2), 2.92 (d, J = 17.5 Hz, 
1H, CH2), 2.82 – 2.69 (m, 1H, CH2CH), 2.61 – 2.47 (m, 1H, CH2CH). 
13C NMR (101 MHz, CDCl3) δ 200.5, 166.4, 154.3, 131.3, 127.1, 126.8, 120.3, 116.2, 109.6, 
67.8, 55.8, 39.0, 37.7. 
IR νmax 2939 (w), 2927 (w), 2844 (w), 2097 (s), 1708 (s), 1598 (s), 1265 (s), 1093 (m), 1024 (m), 
927 (m). 
HRMS (ESI) calcd for C13H13N3NaO2
+ [M+Na]+ 266.0900; found 266.0898. 
[α]D25.0 +10.7 (c = 3.38, CHCl3). 
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(R)-2-azido-5-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7b) 
 
Following general procedure GP4, starting from substrate 4b (0.061 g, 0.20 mmol) (R)-5-
methoxy-2-(2-methylallyl)-2-((triisopropylsilyl)ethynyl)-2,3-dihydro-1H-inden-1-one (7b) (0.066 
mg, 0.26 mmol, 86% yield, 97% ee) was obtained as a yellow oil.  
Chiral HPLC conditions. ee: 97%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 20 min. tR1 = 
8.6 min and tR2 = 10.0 min. λ = 254 cm-1. 
 
RF 0.4 (Dichloromethane:Pentane 2:1).  
 
1H NMR (400 MHz, Chloroform-d) δ 7.72 (d, J = 8.6 Hz, 1H, ArH), 6.93 (dd, J = 8.6, 2.2 Hz, 
1H, ArH), 6.82 (d, J = 2.2 Hz, 1H, ArH), 4.92 (t, J = 1.7 Hz, 1H, CCH2), 4.88 – 4.82 (m, 1H, 
CCH2), 3.88 (s, 3H, OCH3), 3.29 (d, J = 17.5 Hz, 1H, CH2), 2.88 (d, J = 17.6 Hz, 1H, CH2), 2.78 
(d, J = 14.4 Hz, 1H, CH2C), 2.49 (dd, J = 14.5, 1.0 Hz, 1H, CH2C), 1.81 – 1.74 (m, 3H, CH3). 
 
13C NMR (101 MHz, CDCl3) δ 200.4, 166.4, 154.6, 140.3, 126.9, 126.7, 116.2, 116.0, 109.7, 
67.6, 55.8, 41.5, 37.6, 23.4. 
IR νmax 3076 (w), 3075 (w), 3016 (w), 3015 (w), 2970 (w), 2941 (w), 2940 (w), 2929 (w), 2928 
(w), 2927 (w), 2845 (w), 2844 (w), 2101 (s), 1708 (s), 1600 (s), 1599 (s), 1445 (w), 1266 (s), 
1093 (m), 1026 (w), 903 (m), 757 (s).  
HRMS (ESI) calcd for C14H15N3NaO2
+ [M+Na]+ 280.1056; found 280.1057. 
[α]D25.0 +15.3 (c = 3.86, CHCl3). 
 
(R)-2-Azido-5-methyl-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7c) 
Following the general procedure GP4, starting from substrate 4c (0.057 g, 0.20 mmol) (R)-2-
azido-5-methyl-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7c) (0.039 g, 0.16 mmol, 81% 
yield, 96% ee) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 96%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 10 min. tR1 = 
5.7 min and tR2 = 6.6 min. λ = 280 cm-1. 
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RF 0.85 (Pentane:Diethyl Ether 9:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 7.8 Hz, 1H, ArH), 7.25 – 7.19 (m, 2H, ArH), 
4.93 (t, J = 1.6 Hz, 1H, CMeCH2), 4.85 (dd, J = 1.9, 1.0 Hz, 1H, CMeCH2), 3.30 (d, J = 17.5 Hz, 
1H, CH2), 2.90 (d, J = 18.0 Hz, 1H, CH2), 2.79 (dd, J = 14.4, 1.0 Hz, 1H, CH2CMe), 2.50 (dd, J = 
14.4, 1.1 Hz, 1H, CH2CMe), 2.45 (s, 3H, ArCH3), 1.77 (t, J = 1.1 Hz, 3H, CH3). 
 
13C NMR (101 MHz, Chloroform-d) δ 201.9, 152.0, 147.6, 140.2, 131.4, 129.4, 126.9, 125.0, 
116.1, 67.5, 41.5, 37.4, 23.5, 22.3. 
IR νmax 2943 (w), 2924 (w), 2852 (w), 2101 (s), 1715 (s), 1609 (s), 1255 (s), 1254 (s), 904 (m). 
HRMS (ESI) calcd for C14H15N3NaO
+ [M+Na]+ 264.1107; found 264.1110.  
[α]D25.0 +10.4 (c = 2.78, CHCl3). 
 
(R)-2-Azido-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7d) 
Following the general procedure GP4, starting from substrate 4d (0.054 g, 0.20 mmol) (R)-2-
Azido-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7d) (0.035 g, 0.15 mmol, 77% yield, 95% 
ee) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 95%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 15 min tR1 = 
7.0 min and tR2 = 8.4 min. λ = 254 cm-1. 
RF 0.33 (Pentane:Ethyl Acetate 95:5). 
1H NMR (400 MHz, Chloroform-d) δ 7.81 (dd, J = 7.9, 1.1 Hz, 1H, ArH), 7.64 (td, J = 7.5, 1.3 
Hz, 1H, ArH), 7.48 – 7.37 (m, 2H, ArH), 4.94 (m, 1H, CCH2), 4.86 (m, 1H, CCH2), 3.35 (d, J = 
17.5 Hz, 1H, CH2), 2.95 (d, J = 17.5 Hz, 1H, CH2), 2.81 (dd, J = 14.5, 1.0 Hz, 1H, CH2C), 2.51 
(dd, J = 14.6, 1.0 Hz, 1H, CH2C), 1.77 (t, J = 1.1 Hz, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 202.4, 151.5, 140.1, 136.1, 133.7, 128.2, 126.6, 125.2, 
116.2, 67.3, 41.4, 37.6, 23.5. 
IR νmax 3076 (w), 2928 (w), 2856 (w), 2101 (s), 1718 (s), 1606 (m), 1301 (w), 1255 (m), 1222 
(w), 908 (s), 734 (s). 
HRMS (ESI) calcd for C13H13N3NaO
+ [M+Na]+ 250.0951; found 250.0949. 
[α]D25.0 +10.5 (c = 2.83, CHCl3). 
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(R)-2-Azido-5-bromo-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7e) 
Following general procedure GP4, starting from substrate 4e (0.070 g, 0.20 mmol) (R)-2-azido-5-
bromo-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7e) (0.052 g, 0.17 mmol, 85% yield, 90% 
ee) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 90%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 15 min tR1 = 
8.9 min and tR2 = 10.6 min. λ = 254 cm-1. 
RF 0.7 (Pentane:Ethyl Acetate 95:5).  
1H NMR (400 MHz, Chloroform-d) δ 7.67 (dd, J = 8.2, 0.6 Hz, 1H, ArH), 7.62 – 7.52 (m, 2H, 
ArH), 4.94 (t, J = 1.6 Hz, 1H, CMeCH2), 4.87 – 4.80 (m, 1H, CMeCH2), 3.33 (dd, J = 17.6, 0.7 
Hz, 1H, CH2), 2.92 (d, J = 17.7 Hz, 1H, CH2), 2.79 (dd, J = 14.5, 1.1 Hz, 1H, CH2CMe), 2.52 
(dd, J = 14.4, 1.0 Hz, 1H, CH2CMe), 1.76 (dd, J = 1.5, 0.8 Hz, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ. 201.3, 153.0, 139.8, 132.5, 131.9, 131.6, 129.9, 126.3, 
116.4, 67.3, 41.3, 37.2, 23.5. 
IR νmax 3079 (w), 2927 (w), 2857 (w), 2105 (s), 1724 (s), 1596 (s), 1251 (m), 1215 (m), 907 (m). 
HRMS (ESI) calcd for C13H13
79BrNO+ [M-N2+H]
+ 278.0175; found 278.0180. 
[α]D25.0 +12.4 (c = 4.26, CHCl3). 
 
(R)-2-Azido-6-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7f) 
Following general procedure GP4, starting from substrate 4f (0.060 g, 0.20 mmol), (R)-2-azido-
6-methoxy-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7f) (0.029 g, 0.11 mmol, 56% yield, 
89% ee) was obtained as a yellow oil. 
Chiral HPLC conditions: ee: 89%; Chiralcel IC 99.9:0.1 Hexane/iPrOH, 1 mL/min, 20 min tR1 
= 5.4 min and tR2 = 5.9 min, λ = 280 cm-1. 
RF 0.65 (Pentane:Ethyl Acetate 9:1). 
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1H NMR (400 MHz, Chloroform-d) δ 7.30 (ddd, J = 8.0, 1.7, 0.9 Hz, 1H, ArH), 7.25 – 7.21 (m, 
2H, ArH), 4.93 (t, J = 1.6 Hz, 1H, CMeCH2), 4.85 (d, J = 1.0 Hz, 1H, CMeCH2), 3.84 (s, 3H, 
OMe), 3.27 (dd, J = 17.2, 0.8 Hz, 1H, CH2), 2.88 (d, J = 16.9 Hz, 1H, CH2), 2.79 (dd, J = 14.5, 
1.1 Hz, 1H, CH2CMe), 2.51 (dd, J = 14.5, 1.1 Hz, 1H, CH2CMe), 1.76 (t, J = 1.1 Hz, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 202.4, 159.9, 144.4, 140.1, 134.8, 127.3, 125.6, 116.1, 
106.0, 68.1, 55.7, 41.5, 37.0, 23.5. 
IR νmax 3075 (w), 2933 (w), 2841 (w), 2103 (s), 1717 (s), 1491 (s), 1437 (m), 1276 (s), 1242 (s), 
902 (m), 771 (m). 
HRMS (ESI) calcd for C14H15N3NaO2
+ [M+Na]+ 280.1056; found 280.1060. 
[α]D25.0 +3.1 (c = 1.03, CHCl3). 
 
(R)-2-Azido-6-chloro-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7g) 
 
Following general procedure GP4, starting from substrate 4g (0.061 mg, 0.20 mmol) (R)-2-azido-
6-chloro-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7g) (0.046 g, 0.18 mmol, 88% yield, 
87% ee) was obtained as a yellow oil. 
Chiral HPLC conditions: ee: 87%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 20 min tR1 = 
6.4 min and tR2 = 7.9 min. λ = 254 cm-1. 
RF 0.6 (Pentane:Dichloromethane 1:1). 
1H NMR (400 MHz, Chloroform-d) δ 7.76 (d, J = 2.0 Hz, 1H, ArH), 7.59 (dd, J = 8.2, 2.1 Hz, 
1H, ArH), 7.36 (d, J = 8.2 Hz, 1H, ArH), 4.94 (t, J = 1.6 Hz, 1H, CMeCH2), 4.85 (dd, J = 1.9, 1.0 
Hz, 1H, CMeCH2), 3.30 (d, J = 17.6 Hz, 1H, CH2), 2.90 (d, J = 17.6 Hz, 1H, CH2), 2.79 (dd, J = 
14.5, 1.0 Hz, 1H, CH2CMe), 2.51 (dd, J = 14.5, 1.1 Hz, 1H, CH2CMe), 1.76 (t, J = 1.1 Hz, 3H, 
CH3). 
13C NMR (101 MHz, Chloroform-d) δ 201.2, 149.6, 139.8, 136.1, 135.2, 134.5, 127.8, 124.8, 
116.4, 67.8, 41.3, 37.2, 23.5. 
IR νmax 3080 (w), 2925 (w), 2102 (s), 1723 (s), 1469 (w), 1430 (m), 1429 (m), 1285 (w), 1250 
(m), 1208 (m), 1186 (m), 903 (m), 822 (w), 821 (w), 737 (w).  
HRMS (ESI) calcd for C13H13ClNO [M-N2+H]
+ 234.0686; found 234.0688. 
[α]D25.0 +11.7 (c = 3.52, CHCl3). 
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(R)-2-Azido-2-(2-methylallyl)-6-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one (7h) 
Following general procedure GP4, starting from substrate 4h (0.076 g, 0.22 mmol), (R)-2-azido-
2-(2-methylallyl)-6-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one (7h) (0.033 g, 0.11 mmol, 
50% yield, 77% ee) was obtained as a brown oil. 
Chiral HPLC conditions: ee: 77%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 10 min. tR1 = 
5.3 min and tR2 = 6.2 min, λ = 254 cm-1. 
RF 0.35 (Pentane:Dichloromethane 2:1). 
1H NMR (400 MHz, Chloroform-d) δ 8.07 (d, J = 1.7 Hz, 1H, ArH), 7.88 (dd, J = 8.1, 1.7 Hz, 
1H, ArH), 7.57 (d, J = 8.0 Hz, 1H, ArH), 4.99 – 4.91 (m, 1H, CMeCH2), 4.92 – 4.82 (m, 1H, 
CMeCH2), 3.40 (d, J = 17.9 Hz, 1H, CH2), 3.00 (d, J = 17.9 Hz, 1H, CH2), 2.82 (dd, J = 14.6, 1.0 
Hz, 1H, CH2CMe), 2.54 (dd, J = 14.5, 1.1 Hz, 1H, CH2CMe), 1.77 (t, J = 1.1 Hz, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 201.3, 154.7, 139.7, 134.2, 132.4, 131.0 (q, J = 33.2 Hz), 
127.4, 123.5 (q, J = 272.9 Hz), 122.4, 116.5, 67.5, 41.1, 37.7, 23.5. 
19F NMR (376 MHz, Chloroform-d) δ -62.2. 
IR νmax 3019 (w), 2970 (w), 2939 (w), 2930 (w), 2103 (m), 1708 (m), 1600 (m), 1266 (s), 1221 
(m), 756 (s). 
HRMS (ESI) calcd for C13H11F3N3O
+ [M+H]+ 282.0849; found 282.0844. 
[α]D25.0 +6.5 (c = 2.8, CHCl3). 
 
(R)-2-azido-6-fluoro-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7i) 
Following general procedure GP4, starting from .substrate 4i (0.058 g, 0.20 mmol), (R)-2-azido-
6-fluoro-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7i) (0.036 g, 0.15 mmol, 73% yield, 
92% ee) was obtained as a yellow oil.  
Chiral HPLC conditions: ee: 92%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
6.3 min and tR2 = 6.9 min. λ = 230 cm-1 
RF 0.3 (Pentane: Dichloromethane 2:1). 
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1H NMR (400 MHz, Chloroform-d) δ 7.44 (dd, J = 7.2, 2.4 Hz, 1H, ArH, ArH), 7.42 – 7.32 (m, 
2H, ArH), 4.94 (t, J = 1.6 Hz, 1H, CMeCH2), 4.85 (dt, J = 2.0, 1.0 Hz, 1H, CMeCH2), 3.31 (d, J 
= 17.3 Hz, 1H, CH2), 2.91 (d, J = 17.4 Hz, 1H, CH2), 2.79 (dd, J = 14.4, 1.0 Hz, 1H, CH2CMe), 
2.52 (dd, J = 14.6, 1.0 Hz, 1H, CH2CMe), 1.76 (s, 3H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 201.7, 162.6 (d, J = 249.4 Hz), 147.0, 139.8, 135.4, 
128.1, 123.9 (d, J = 23.8 Hz), 116.4, 110.9 (d, J = 22.0 Hz), 68.1, 41.3, 37.1, 23.5. 
19F NMR (376 MHz, Chloroform-d) δ -113.0. 
IR νmax 3076 (w), 2929 (w), 2858 (w), 2104 (m), 1723 (m), 1488 (m), 1441 (w), 1265 (m), 1227 
(m), 1226 (m), 758 (s). 
HRMS (ESI) calcd for C13H13FNO
+ [M-N2+H]
+ 218.0976; found 218.0980. 
[α]D25.0 +10.5 (c = 3.11, CHCl3). 
 
(R)-2-Azido-4-bromo-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7j) 
Following general procedure GP4, starting from substrate 4j (0.070 g, 0.20 mmol), (R)-2-azido-
4-bromo-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (7j) (0.052 g, 0.12 mmol, 85% yield, 
87% ee) was obtained as a yellow oil. 
Chiral HPLC conditions: ee: 87%; Chiralcel IA 99:1 Hexane/iPrOH, 1 mL/min, 10 min tR1 = 
5.5 min and tR2 = 6.2 min, λ = 254 cm-1. 
RF 0.75 (Pentane:Ethyl Acetate 95:5). 
1H NMR (400 MHz, Chloroform-d) δ 7.81 (dd, J = 7.8, 1.0 Hz, 1H, ArH), 7.77 (dd, J = 7.6, 0.9 
Hz, 1H, ArH), 7.38 – 7.29 (m, 1H, ArH), 5.00 – 4.94 (m, 1H, CMeCH2), 4.89 (dd, J = 1.8, 0.9 
Hz, 1H, CMeCH2), 3.27 (d, J = 18.0 Hz, 1H, CH2), 2.89 (d, J = 18.0 Hz, 1H, CH2), 2.83 (dd, J = 
14.5, 1.1 Hz, 1H, CH2CMe), 2.53 (dd, J = 14.6, 1.1 Hz, 1H, CH2CMe), 1.78 (s, 2H, CH3). 
13C NMR (101 MHz, Chloroform-d) δ 201.8, 151.3, 139.6, 138.8, 135.7, 129.9, 123.9, 122.0, 
116.5, 67.2, 41.2, 38.8, 23.5. 
IR νmax 3076 (w), 3020 (w), 2941 (w), 2846 (w), 2103 (m), 1709 (w), 1602 (m), 1333 (w), 1267 
(m), 1219 (m), 1135 (w), 1109 (w), 1095 (w), 905 (w), 756 (s). 
HRMS (ESI) calcd for C13H12NO
79Br+ [M-N2]
+ 280.0161; found 280.0165. 
[α]D25.0 +4.0 (c = 1.58, CHCl3). 
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(S)-2-Azido-2-(2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl)-5-methoxy-2,3-dihydro-1H-
inden-1-one (7k)  
Following general procedure GP4, starting from substrate 4k (0.11 g, 0.20 mmol), (S)-2-azido-2-
(2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl)-5-methoxy-2,3-dihydro-1H-inden-1-one (7k) 
(0.052 g, 0.10 mmol, 51 % yield, 97% ee) was obtained as a yellow oil. 
Chiral HPLC conditions: ee: 97%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 15 min tR1 = 
7.0 min and tR2 = 8.4 min. λ = 254 cm-1. 
 
RF 0.37 (Dichloromethane:Pentane 5:1). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J = 8.6 Hz, 1H, ArH), 7.65 (m, 4H, Ph), 7.47 – 
7.34 (m, 6H, Ph), 6.92 (dd, J = 8.6, 2.3 Hz, 1H, ArH), 6.77 (d, J = 2.2 Hz, 1H, ArH), 5.36 (d, J = 
1.7 Hz, 1H, CCH2), 5.08 (d, J = 1.3 Hz, 1H, CCH2), 4.20 (d, J = 14.2 Hz, 1H, CH2OTBDPS), 
4.10 (d, J = 14.3 Hz, 1H, CH2OTBDPS), 3.88 (s, 3H, OMe), 3.26 (d, J = 17.5 Hz, 1H, CH2), 2.81 
(d, J = 17.7 Hz, 1H, CH2), 2.80 (d, J = 14.9 Hz, 1H, CH2CCH2), 2.51 (dd, J = 14.9, 1.0 Hz, 1H, 
CH2CCH2), 1.06 (s, 9H, tBu). 
 
13C NMR (101 MHz, Chloroform-d) δ 200.2, 166.4, 154.6, 142.6, 135.5, 135.5, 133.4, 133.4, 
129.7, 127.7, 126.9, 126.7, 116.2, 114.4, 109.7, 67.7, 66.7, 55.8, 37.8, 36.7, 26.9, 19.3.20  
 
IR νmax 2950 (w), 2102 (m), 1709 (m), 1600 (s), 1266 (s), 1109 (s), 912 (m), 824 (s). 
 
HRMS (ESI) calcd for C30H33N3NaO3Si
+ [M+Na]+ 534.2183; found 534.2177. 
 
[α]D25.0 +8.10 (c = 4.40, CHCl3). 
 
5.3 General procedure GP5 for the asymmetric decarboxylation of α-cyano allyl β-
keto esters catalyzed by Pd. 
                                                 
20 Two C in the aromatic region are not resolved. 
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Substrate 5 (0.2 mmol), Pd2(dba)3 (29, 2.5 mol%) and ligand 6a (5.5 mol%) were placed in a 
micro wave vial which was sealed. The solvent MTBE (20 mL, 0.01M) was added and the 
reaction was immediately degased three times. The reaction was then monitored by TLC. After 
12 hours the starting material was consumed and the solvent evaporated. Purification by column 
chromatography using the solvent mixture indicated for the RF of each compound yielded the 
product that was analyzed by chiral HPLC. The procedure used for optimization and scope is the 
same.  
 
Reaction Optimization for Allyl substrate 
 
Supplementary Table S5 ǀ Screening of the Solvent 
 
 
 
Entry Solvent Yield%a ee%a 
1 THF 99 68 
2 DCM 95 50 
3 Toluene n.r. - 
4 CH
3
CN 82 45 
5 Et
2
O 98 61-78b 
6 MTBE 93 70 
7 iPr2O 99 71 
8 nBu
2
O >99 67 
9 Ph
2
O 94 49 
10 dioxane 94 39 
a) Substrate 5a (0.037 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), 6a (11 mol%) and solvent (0.4 M) at 25 °C. 
Isolated yield after flash chromatography is given, the ee are measured with chiral HPLC. b) Not reproducible. 
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Supplementary Table S6 ǀ Screening of the Temperature 
 
 
 
Entry Temperature Yield% ee %a 
1 -20°C 97 57 
2 0°C 98 59 
3 r.t 98 78 
4 40°C >99 57 
a) Substrate 5a (0.037 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), 6a (11 mol%) and Et2O (0.4 M). Isolated yield 
after flash chromatography is given, the ee are measured with chiral HPLC. 
 
Supplementary Table S7 ǀ Screening of Ligands 
 
 
 
Entry Ligand Yield% ee %a 
1 Stoltz 6e 94 0 
2 Dach 6b 92 23 
3 Dach Naphtyl 6a 98 78 
4 Anden 6d 94 31 
5 DiPhenyl 6c >99 47 
a) Substrate 11a (0.037 mmol), Pd[(Cinnamyl)Cp] (34, 10 mol%), L (11 mol%) and Et2O (0.4 M) at 25 °C. Isolated 
yield after flash chromatography is given, the ee are measured with chiral HPLC. 
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Supplementary Table S8 ǀ Screening of Concentrations 
 
 
 
Entry Concentration Yield% ee %a 
1 0.04 M 98 59 
2 0.1 M 98 61 
3 0.3 M 93 55 
4 0.4 M 98 78 
5 0.5 M 91 41 
6 1 M 91 49 
a) Substrate 5a (0.037 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), 6a (11 mol%) and Et2O (X M) at 25 °C. Isolated 
yield after flash chromatography is given, the ee are measured with chiral HPLC. 
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Supplementary Table S9 ǀ Pd:Ligand loading and ratio 
 
 
 
Entry Pd:Ligand Yield% ee %a 
1 2.5/2.75% n.rb - 
2 5/5.5% 92 47 
3 5/10% 97 43 
4 5/20% 93 49 
5 10/11% 98 78 
a) Substrate 5a (0.037 mmol), Pd[(Cinnamyl)Cp] (30, X mol%), 6a (X mol%) and Et2O (0.4 M) at 25 °C. Isolated 
yield after flash chromatography is given, the ee are measured with chiral HPLC. b) No complete conversion after 48 
hours. 
 
 
Reaction Optimization for Methylallyl Substrate 
 
Supplementary Table S10 ǀ Screening of the Solvent 
 
 
 
Entry Solvent Yield% ee %a 
1 THF 84 60 
2 DCM 77 70 
3 Toluene 86 68 
4 CH
3
CN 82 61 
5 Et
2
O 71 79 
6 MTBE 89 78 
7 Methyl-Cyclopentyl 
ether 
94 53 
8 DMF 80 42 
9 DMSO 78 29 
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a) Substrate 5b (0.035 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), 6a (11 mol%) and solvent (0.4 M) at 25 °C. 
Isolated yield after flash chromatography is given, the ee are measured with chiral HPLC. 
 
Supplementary Table S11 ǀ Screening of the Temperature 
 
 
 
Entry Temperature Yield% ee %a 
1 -10°C 84 72% 
2 0°C 83 59% 
3 r.t. 89 78% 
4 40°C 82 74% 
 a) Substrate 5b (0.035 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), 6a (11 mol%) and MTBE (0.4 M). Isolated yield 
after flash chromatography is given, the ee are measured with chiral HPLC. 
 
Supplementary Table S12 ǀ Screening of Ligands 
 
 
 
Entry Ligand Yield% ee %a 
1 Stoltz 6e 86 1.4% 
2 Dach 6b  83 48% 
3 Dach Naphtyl 6a 89 78% 
4 Anden 6c 84 40% 
5 DiPhenyl 6d 82 41% 
6 6f 95 1.6% 
7 6g n.rb - 
8 6h 90 38% 
9 6i 85 25% 
a) Substrate 5b (0.035 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), L (11 mol%) and MTBE (0.4 M) at 25 °C. Isolated 
yield after flash chromatography is given, the ee are measured with chiral HPLC. b) No complete conversion after 48 
hours. 
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Supplementary Table S13 ǀ Screening of Concentrations 
 
 
 
Entry Concentration Yield%   ee %a 
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1 0.001 M 92 60% 
2 0.005 M 92 59% 
3 0.01 M 83 86% 
4 0.033 M 84 84% 
5 0.04 M 85 81% 
6 0.1 M 83 81% 
7 0.4 M 89 78% 
8 1 M 79 72% 
a) Substrate 5b (0.035 mmol), Pd[(Cinnamyl)Cp] (30, 10 mol%), 6a (11 mol%) and MTBE (X M) at 25 °C. Isolated 
yield after flash chromatography is given, the ee are measured with chiral HPLC. 
 
 
Supplementary Table S14 ǀ Screening of Catalyst/Ligand Loading 
 
 
 
Entry Catalyst/Ligand Yield% ee %a 
1 2.5/2.75% n.rb - 
2 5/5.5% n.rb 86% 
3 5/10% 91 83% 
4 5/20% 86 85% 
5 10/11% 89 86% 
a) Substrate 11b (0.035 mmol), Pd[(Cinnamyl)Cp] (34, X mol%), L (X mol%) and MTBE (0.01 M) at 25 °C. 
Isolated yield after flash chromatography is given, the ee are measured with chiral HPLC. b) No complete conversion 
after 48 hours. 
 
Supplementary Table S15 ǀ Screening of the Palladium Source 
 
 
 
Entry Palladium Source Yield% ee %a 
1 Pd(dba)
2
 10% - Dach 
Naphtyl 11 % 
87 77% 
2 Pd
2
(dba)
3
 5% - Dach 87 88% 
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Naphtyl 11 % 
3 Pd2(dba)3 2.5% - 
Dach Naphtyl 5.5% 
87 89% 
a) Substrate 5b (0.035 mmol), Pd source (X mol%), L 6a (X mol%) and MTBE (0.01 M) at 25 °C. Isolated yield 
after flash chromatography is given, the ee are measured with chiral HPLC. 
  
(S)-2-Allyl-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8a) 
 
Following general procedure GP5, but using PdCynnamylCp (30) (0.006 g, 0.02 mmol, 5 mol%) 
as catalyst, starting from substrate 5a (0.054 g, 0.20 mmol), (S)-5-methoxy-2-(2-methylallyl)-1-
oxo-2,3-dihydro-1H-indene-2-carbonitrile (8a) (0.041 g, 0.18 mmol, 91 % yield, 79% ee) was 
obtained as an yellow oil.  
RF 0.5 (Pentane: Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 79%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
19.1 min and tR2 = 23.4 min. λ = 280 cm-1. 
1H NMR (400 MHz, Chloroform-d) δ 7.76 (d, J = 8.6 Hz, 1H, ArH), 6.98 (dd, J = 8.7, 2.2 Hz, 
1H, ArH), 6.92 – 6.82 (m, 1H, ArH), 5.81 (m, 1H, CHCH2), 5.35 – 5.16 (m, 2H, CCH2), 3.91 (s, 
3H, OMe), 3.52 (d, J = 17.4 Hz, 1H, CH2), 3.29 (d, J = 17.4 Hz, 1H, CH2), 2.82 (dd, J = 13.9, 6.7 
Hz, 1H, CH2CH), 2.47 (dd, J = 13.9, 7.6 Hz, 1H, CH2CH). 
13C NMR (101.00 MHz, Chloroform-d) δ 195.5, 166.8, 153.9, 130.9, 127.4, 126.5, 121.2, 
119.8, 116.9, 109.8, 56.0, 47.5, 40.8, 37.2. 
IR νmax  3084 (w), 2945 (w), 2929 (w), 2845 (w), 2239 (w), 1718 (s), 1601 (s), 1492 (w), 1437 
(w), 1268 (s), 1150 (w), 1093 (m), 1025 (m). 
HRMS (ESI) calcd for C14H14NO2
+ [M+H]+ 228.1019; found 228.1022. 
[α]D25.0 +50.4 (c = 11.0, CHCl3). 
 
(S)-5-Methoxy-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8b) 
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Following general procedure GP5, starting from substrate 5b (0.057 g, 0.20 mmol), (S)-5-
methoxy-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8b) (0.044 g, 0.18 
mmol, 92% yield, 89% ee) was obtained as an orange resin.  
RF 0.4 (Pentane: Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 89%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
16.4 min and tR2 = 22.8 min. λ = 254 cm-1. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.75 (d, J = 8.6 Hz, 1H, ArH), 6.98 (dd, J = 8.6, 2.2 Hz, 
1H, ArH), 6.88 (s, 1H, ArH), 4.99 (s, 1H, CCH2), 4.88 (s, 1H, CCH2), 3.91 (s, 3H, OMe), 3.53 (d, 
J = 17.5 Hz, 1H, CH2), 3.37 (d, J = 17.5 Hz, 1H, CH2), 2.84 (d, J = 14.5 Hz, 1H, CH2CMe), 2.38 
(d, J = 14.5 Hz, 1H, CH2CMe), 1.84 (d, J = 1.5 Hz, 3H, CH3). 
 
13C NMR (101.00 MHz, Chloroform-d) δ 195.8, 166.8, 154.1, 139.9, 127.5, 126.1, 120.4, 
116.9, 116.6, 109.8, 56.0, 46.9, 43.7, 37.3, 23.3. 
IR νmax 3082 (w), 2945 (w), 2922 (w), 2844 (w), 2238 (w), 1715 (s), 1599 (s), 1492 (w), 1265 
(s), 1089 (m), 1023 (m), 909 (m). 
HRMS (ESI) calcd for C15H16NO2
+ [M+H]+ 242.1176; found 242.1169. 
[α]D25.0  +61.6 (c = 3.1, CHCl3). 
 
(S)-5-Methyl-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8c) 
 
Following general procedure GP5, starting from substrate 5c (0.054 g, 0.20 mmol), (S)-5-methyl-
2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8c) (0.044 g, 0.19 mmol, 98% 
yield, 82% ee) was obtained as white crystal.  
RF 0.35 (Pentane:Ethyl acetate 4:1).  
Mp 42-45 °C. 
Chiral HPLC conditions: ee: 82%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
10.0 min and tR2 = 15.4 min. λ = 254 cm-1. 
1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 8.2 Hz, 1H, ArH), 7.26 (m, 2H, ArH21), 5.00 
(s, 1H, CCH2), 4.87 (s, 1H, CCH2), 3.55 (d, J = 17.4 Hz, 1H, CH2), 3.38 (d, J = 17.4 Hz, 1H, 
CH2), 2.84 (d, J = 14.4 Hz, 1H, CH2CMe), 2.47 (s, 3H, ArCH3), 2.43 – 2.29 (m, 1H, CH2CMe), 
1.85 (d, J = 1.1 Hz, 3H, CH3). 
                                                 
21 CDCl3 peak overlaps with the aromatic protons of the molecule. 
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13C NMR (101.00 MHz, Chloroform-d) δ 197.3, 151.5, 148.3, 139.9, 130.9, 130.1, 127.1, 
125.6, 120.3, 116.7, 46.9, 43.7, 37.2, 23.3, 22.4. 
IR νmax 3079 (w), 2975 (w), 2924 (w), 2857 (w), 2238 (w), 1720 (s), 1609 (s), 1435 (w), 1275 
(m), 1120 (w), 909 (m) 
HRMS (ESI)  calcd for C15H16NO
+ [M+H]+ 226.1226; found 226.1220. 
[α]D25.0 +52.2 (c = 3.6, CHCl3). 
 
(S)-2-(2-Methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8d) 
 
Following general procedure GP5, starting from substrate 5d (0.051 g, 0.20 mmol), (S)-2-(2-
methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8d) (0.041 g, 0.19 mmol, 96% yield, 
85% ee) was obtained as an orange oil.  
RF 0.25 (Pentane: Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 85%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
8.5 min and tR2 = 11.3 min. λ = 254 cm-1. 
 
1H NMR (400 MHz, Chloroform-d) 7.84 (d, J = 7.7 Hz, 1H, ArH), 7.77 – 7.66 (m, 1H, ArH), 
7.57 – 7.41 (m, 2H, ArH), 5.01 (s, 1H, CCH2), 4.89 (s, 1H, CCH2), 3.61 (d, J = 17.4 Hz, 1H, 
CH2), 3.44 (d, J = 17.4 Hz, 1H, CH2), 2.85 (d, J = 14.5, 1H, CH2CMe), 2.39 (d, J = 14.5, 1H, 
CH2CMe), 1.85 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 197.8, 151.0, 139.8, 136.6, 133.2, 128.8, 126.8, 
125.8, 120.1, 116.8, 46.7, 43.7, 37.4, 23.3 
IR νmax 3076 (w), 2974 (w), 2923 (w), 2856 (w), 2239 (w), 1731 (s), 1612 (w), 1466 (w), 1436 
(w), 1301 (w), 1214 (w), 1016 (w), 912 (w) 
HRMS (ESI) calcd for C14H14NO
+ [M+H]+ 212.1070; found 212.1063. 
[α]D25.0 +9.3 (c = 3.1, CHCl3). 
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(S)-5-Bromo-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8e) 
 
Following general procedure GP5, starting from substrate 5e (0.067 mg, 0.20 mmol), (S)-5-
bromo-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8e) (0.052 mg, 0.18 mmol, 
90% yield, 78% ee) was obtained as an orange oil.  
RF 0.75 (Pentane:Ethyl acetate 9:1).  
Chiral HPLC conditions: ee: 78%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
10.0 min and tR2 = 16.9 min. λ = 280 cm-1. 
1H NMR (400 MHz, Chloroform-d) δ 7.75 – 7.66 (m, 2H, ArH), 7.62 (d, J = 8.2 Hz, 1H, ArH), 
5.01 (s, 1H, CCH2), 4.87 (s, 1H, CCH2), 3.58 (d, J = 17.8 Hz, 1H, CH2), 3.42 (d, J = 17.6 Hz, 1H, 
CH2), 2.84 (d, J = 14.4 Hz, 1H, CH2CMe), 2.40 (d, J = 14.4 Hz, 1H, CH2CMe), 1.84 (s, 3H, 
CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ  196.6, 152.4, 139.5, 132.6, 132.3, 132.1, 130.1, 
126.9, 119.6, 117.1, 46.8, 43.7, 36.9, 23.3. 
IR νmax 3081 (w), 2925 (w), 2852 (w), 2239 (w), 1729 (s), 1596 (s), 1578 (m), 1416 (w), 1318 
(m), 1265 (m), 1209 (m), 1061 (m), 912 (m). 
HRMS (ESI) calcd for C14H13
79BrNO+ [M+H]+ 290.0175; found 290.0174. 
[α]D25.0 +26.9 (c = 2.3, CHCl3). 
 
(S)-6-Fluoro-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8f) 
 
Following general procedure GP5, starting from substrate 5f (0.055 g, 0.20 mmol), (S)-6-fluoro-
2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8f) (0.037 g, 0.16 mmol, 81% 
yield, 78% ee) was obtained as an orange oil.  
RF 0.8 (Pentane:Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 78%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 30 min. tR1 = 
8.2 min and tR2 = 9.6 min. λ = 280 cm-1. 
S54 
 
 
1H NMR (400 MHz, Chloroform-d) δ 7.54 – 7.35 (m, 3H, ArH), 5.01 (s, 1H, CCH2), 4.87 (s, 
1H, CCH2), 3.57 (d, J = 17.5 Hz, 1H, CH2), 3.40 (d, J = 17.5 Hz, 1H, CH2), 2.83 (d, J = 14.5 Hz, 
1H, CH2CMe), 2.41 (d, J = 14.5 Hz, 1H, CH2CMe), 1.84 (s, 3H, CH3). 
 
13C NMR (101.00 MHz, Chloroform-d) δ 196.8, 162.8 (d, J = 250.5 Hz), 146.3 (d, J = 2.0 Hz), 
139.4, 134.9, 134.8 (d, J = 7.8 Hz), 128.2 (d, J = 8.1 Hz), 124.4 (d, J = 23.8 Hz), 119.6, 116.9, 
111.3 (d, J = 22.4 Hz), 47.5, 43.5, 36.7, 23.2. 
IR νmax  3730 (w), 3625 (w), 3076 (w), 2926 (w), 2856 (w), 2241 (w), 1732 (s), 1614 (w), 1490 
(m), 1442 (m), 1268 (m), 908 (w). 
HRMS (ESI)  calcd for C14H13FNO
+ [M+H]+ 230.0976; found 230.0975. 
[α]D25.0 +21.5 (c = 3.6, CHCl3). 
 
(R)-2-(2-(((tert-butyldiphenylsilyl)oxy)methyl)allyl)-5-methoxy-1-oxo-2,3-dihydro-1H-
indene-2-carbonitrile (8g) 
 
Following general procedure GP5, starting from substrate  5g (0.108 g, 0.200 mmol), (R)-2-(2-
(((tert-butyldiphenylsilyl)oxy)methyl)allyl)-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carbonitrile (8g) (0.046 g, 0.090 mmol, 46% yield, 93% ee) was obtained as white oil after 48 
hours of reaction.  
RF 0.55 (Pentane:Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 93%; Chiralcel IC 95:5 Hexane/iPrOH, 1 mL/min, 25 min. tR1 = 
8.2 min and tR2 = 9.6 min. λ = 254 cm-1. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.73 (d, J = 8.6 Hz, 1H, ArH), 7.68 – 7.60 (m, 4H, ArH), 
7.47 – 7.33 (m, 6H, ArH), 6.96 (dd, J = 8.6, 2.2 Hz, 1H, ArH), 6.80 (d, J = 2.2 Hz, 1H, ArH), 
5.38 (s, 1H, CCH2), 5.16 (s, 1H, CCH2), 4.21 (d, J = 14.3 Hz, 1H, CH2O), 4.10 (d, J = 14.1 Hz, 
1H, CH2O), 3.90 (s, 3H, OMe), 3.46 (d, J = 17.5 Hz, 1H, CH2CCH2), 3.35 (d, J = 17.5 Hz, 1H, 
CH2CCH2), 2.86 (d, J = 14.8 Hz, 1H, CH2), 2.42 (d, J = 14.8 Hz, 1H, CH2), 1.05 (s, 9H, 
SiC(CH3)3). 
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13C NMR (101.00 MHz, Chloroform-d) δ 195.7, 166.8, 154.2, 142.2, 135.6, 133.4, 133.3, 
129.9, 127.9, 127.5, 126.2, 120.1, 116.9, 115.2, 109.8, 77.4, 66.7, 56.0, 47.4, 38.5, 37.6, 27.0, 
19.4.22 
IR νmax  3072 (w), 2958 (w), 2932 (w), 2857 (w), 2238 (w), 1718 (s), 1601 (s), 1429 (m), 1267 
(s), 1113 (s), 912 (m), 827 (m) 
HRMS (ESI)  calcd for C31H33NNaO3Si
+ [M+Na]+ 518.2122; found 518.2138. 
[α]D25.0  +30.6 (c = 1.1, CHCl3). 
 
(S)-5-Methoxy-1-oxo-2-(2-phenylallyl)-2,3-dihydro-1H-indene-2-carbonitrile (8h) 
 
Following general procedure GP5, starting from substrate 5h (0.070 g, 0.20 mmol), (S)-5-
methoxy-1-oxo-2-(2-phenylallyl)-2,3-dihydro-1H-indene-2-carbonitrile (8h) (0.052 g, 0.17 
mmol, 86% yield, 88% ee) was obtained as yellow oil after 48 hours of reaction.  
RF 0.55 (Pentane:Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 88%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 35 min. tR1 = 
23.7 min and tR2 = 30.0 min. λ = 254 cm-1.  
1H NMR (400 MHz, Chloroform-d) δ 7.63 (d, J = 8.6 Hz, 1H, ArH), 7.31 – 7.20 (m, 5H, 
ArH23), 6.92 (dd, J = 8.7, 2.2 Hz, 1H, ArH), 6.72 (d, J = 2.2 Hz, 1H, ArH), 5.39 (s, 1H, CCH2), 
5.32 (s, 1H, CCH2), 3.87 (s, 3H, OMe), 3.39 – 3.26 (m, 2H, CH2CPh+ CH2), 3.17 (d, J = 17.5 Hz, 
1H, CH2CPh), 2.98 (dd, J = 14.3, 1.0 Hz, 1H, CH2).  
13C NMR (101.00 MHz, Chloroform-d) δ 195.6, 166.7, 154.2, 143.1, 140.7, 135.7, 128.6, 
128.2, 127.3, 126.7, 119.9, 119.1, 116.9, 109.5, 56.0, 48.1, 41.3, 37.2.  
IR 3057 (w), 3022 (w), 2930 (w), 2851 (w), 2239 (w), 1719 (s), 1601 (s), 1493 (w), 1447 (w), 
1268 (s), 1092 (m), 1026 (w), 914 (w).  
HRMS (ESI)  calcd for C20H18NO2
+ [M+H]+ 304.1332; found 304.1321.  
[α]D25.0 +32.0 (c = 1.2, CHCl3). 
 
                                                 
22 Not all carbons resolved in the spectra. 
23 CDCl3 peak overlaps with the aromatic protons of the molecule 
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(R)-2-(2-Chloroallyl)-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carbonitrile (8i) 
 
Following general procedure GP5, starting from substrate 5i (0.061 g, 0.20 mmol), (R)-5-
methoxy-1-oxo-2-(2-phenylallyl)-2,3-dihydro-1H-indene-2-carbonitrile (8i) (0.039 g, 0.15 mmol, 
75% yield, 92% ee) was obtained as yellow oil after 6 hours of reaction.  
RF 0.30 (Pentane:Ethyl acetate 4:1).  
Chiral HPLC conditions: ee: 92%; Chiralcel IA 95:5 Hexane/iPrOH, 1 mL/min, 35 min. tR1 = 
20.6 min and tR2 = 33.4 min. λ = 254 cm-1. 
 
1H NMR (400 MHz, Chloroform-d) δ 7.77 (d, J = 8.6 Hz, 1H, ArH), 6.99 (dd, J = 8.6, 2.3 Hz, 
1H, ArH), 6.95 – 6.87 (m, 1H, ArH), 5.45 (s, 2H, CCH2), 3.92 (s, 3H, OMe), 3.63 (s, 2H, 
CH2CCl), 3.21 (d, J = 14.8 Hz, 1H, CH2), 2.71 (d, J = 14.8 Hz, 1H, CH2). 
 
13C NMR (101.00 MHz, Chloroform-d) δ 194.6, 167.0, 154.3, 135.9, 127.6, 126.1, 119.2, 
118.5, 117.2, 109.8, 56.1, 47.6, 44.3, 37.6. 
IR νmax  2923 (w), 2849 (w), 2239 (w), 1717 (s), 1599 (s), 1493 (w), 1341 (w), 1303 (m), 1263 
(s), 1149 (w), 1092 (m), 1022 (m), 908 (w). 
HRMS (ESI)  calcd for C14H13ClNO2
+ [M+H]+ 262.0629; found 262.0621. 
[α]D25.0  +98.0 (c =  1.6, CHCl3). 
 
6. Product Modifications 
(R)-2-(4-(4-Bromophenyl)-1H-1,2,3-triazol-1-yl)-6-chloro-2-(2-methylallyl)-2,3-dihydro-1H-
inden-1-one (10a) 
 
Following a reported procedure,24 in an open flask (R)-2-azido-6-chloro-2-(2-methylallyl)-2,3-
dihydro-1H-inden-1-one (7g) (0.020 g, 0.075 mmol), 1-bromo-4-ethynylbenzene 9 (0.014 g, 
0.080 mmol, 1.2 equiv) and TBTA (0.4 mg, 0.7 µmol, 0.01 equiv) were dissolved in tBuOH (0.3 
                                                 
24 Q.H. Deng, T. Bleith, H. Wadepohl, and L.H. Gade, J. Am. Chem. Soc. 2013, 135, 5356. 
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mL, then sodium ascorbate (0.006 g, 0.03 mmol, 0.4 equiv) and copper sulphate pentahydrate 
(0.004 g, 0.02 mmol, 0.2 equiv) dissolved in H2O (0.15 mL), were added under vigorous stirring 
and the reaction monitored by TLC (4:1 Pentane:EtOAc). Upon consumption of the starting 
material the reaction mixture was diluted with water (5 mL) and extracted with DCM (3x5 mL). 
The combined organic layers were dried over MgSO4 and the solvent removed in vacuo. The 
crude was then purified with flash chromatography (4:1 Pentane:EtOAc) to afford (R)-2-(4-(4-
bromophenyl)-1H-1,2,3-triazol-1-yl)-6-chloro-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one 
(10a) as a white oil (0.031 g, 0.070 mmol, 94% yield) 
 
Rf: 0.31 (Pentane:Ethyl Acetate 4:1). 
 
1H NMR (400 MHz, Chloroform-d) δ 8.34 (s, 1H, ArH), 7.78 (d, J = 2.0 Hz, 1H, ArH), 7.77 – 
7.70 (m, 2H, ArH), 7.67 (dd, J = 8.2, 2.1 Hz, 1H, ArH), 7.62 – 7.45 (m, 3H, ArH), 4.89 (s, 1H, 
CCH2), 4.69 (s, 1H, CCH2), 4.63 (d, J = 18.0 Hz, 1H, CH2CMe), 3.78 (d, J = 18.0 Hz, 1H, 
CH2CMe), 2.98 (d, J = 14.5 Hz, 1H, CH2), 2.80 (dd, J = 14.6, 1.1 Hz, 1H, CH2), 1.49 (s, 3H, 
CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 199.5, 150.2, 147.2, 138.7, 136.9, 135.0, 134.7, 
132.1, 129.6, 128.0, 127.4, 125.2, 122.3, 119.1, 117.6, 71.1, 46.3, 36.5, 23.3. 
IR νmax  3148 (w), 3080 (w), 2921 (w), 1726 (s), 1477 (s), 1428 (s), 1256 (m), 1200 (m), 1184 
(m), 1070 (m), 1010 (s) 
HRMS (ESI)  calcd for C21H18
79BrClN3O
+ [M+H]+ 442.0316; found 442.0308. 
[α]D25.0  +53.2 (c = 0.2, CHCl3). 
(R)-2-(4-(4-Bromophenyl)-1H-1,2,3-triazol-1-yl)-6-fluoro-2-(2-methylallyl)-2,3-dihydro-1H-
inden-1-one (10b) 
 
Following a reported procedure,21 in an open flask (R)-2-azido-6-fluoro-2-(2-methylallyl)-2,3-
dihydro-1H-inden-1-one (7i) (0.017 g, 0.070 mmol), 1-bromo-4-ethynylbenzene 9 (0.013 g, 
0.071 mmol, 1.2 equiv ) and TBTA (0.4 mg, 0.7 µmol, 0.01 equiv) were dissolved in tBuOH (0.3 
mL), then sodium ascorbate (0.006 g, 0.03 mmol, 0.4 equiv) and copper sulphate pentahydrate 
(0.003 g, 0.01 mmol, 0,2 equiv) dissolved in H2O (0.15 mL), were added under vigorous stirring 
and the reaction monitored by TLC (4:1 Pentane:EtOAc). Upon consumption of the starting 
material the reaction mixture was diluted with water (5 mL) and extracted with DCM (3x5 mL). 
The combined organic layers were dried over MgSO4 and the solvent removed in vacuo. The 
crude was then purified with flash chromatography (4:1 Pentane:EtOAc) to afford (R)-2-(4-(4-
bromophenyl)-1H-1,2,3-triazol-1-yl)-6-fluoro-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one 
(10b) as a white oil ( 0.029 g, 0.070 mmol, 96% yield) 
 
Rf: 0.35 (4:1 Pentane:Ethyl Acetate 4:1). 
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1H NMR (400 MHz, Chloroform-d) δ  8.34 (s, 1H, ArH), 7.73 (d, J = 8.5 Hz, 2H, ArH), 7.55 
(m, 3H, ArH), 7.50 – 7.39 (m, 2H, ArH), 4.89 (s, 1H, CCH2), 4.70 (s, 1H, CCH2), 4.63 (d, J = 
17.7 Hz, 1H, CCH2), 3.78 (d, J = 17.7 Hz, 1H, CCH2), 2.99 (d, J = 14.5 Hz, 1H, CH2), 2.82 (d, J 
= 14.5 Hz, 1H, CH2), 1.49 (s, 3H, CH3). 
13C NMR (101.00 MHz, Chloroform-d) δ 199.9 (d, J = 3.0 Hz), 162.8 (d, J = 250.0 Hz), 147.6 
(d, J = 2.2 Hz), 147.2, 138.7, 134.9 (d, J = 7.7 Hz), 132.1, 129.6, 128.4 (d, J = 7.9 Hz), 127.4, 
124.8 (d, J = 23.8 Hz), 122.3, 119.1, 117.6, 111.2 (d, J = 22.2 Hz), 71.4, 46.3, 36.4, 23.3. 
IR νmax  3149 (w), 3076 (w), 2922 (w), 2854 (w), 1726 (s), 1488 (s), 1441 (m), 1267 (s), 1070 
(m), 1011 (m). 
HRMS (ESI)  calcd for C21H18
79BrFN3O
+ [M+H]+ 426.0612; found 426.0608. 
[α]D25.0  +15.0 (c = 0.1 g/mL, CHCl3). 
 
 
(R)-4-Bromo-2-(4-(4-bromophenyl)-1H-1,2,3-triazol-1-yl)-2-(2-methylallyl)-2,3-dihydro-1H-
inden-1-one (10c) 
 
Following a reported procedure,21 in an open flask, (R)-2-azido-4-bromo-2-(2-methylallyl)-2,3-
dihydro-1H-inden-1-one (7j) (0.043 g, 0.14 mmol), 1-bromo-4-ethynylbenzene 9 (0.025 g, 0.14 
mmol, 1.2 equiv) and TBTA (0.70 mg, 1.4 µmol, 0.01 equiv) were dissolved in tBuOH (0.6 mL, 
then sodium ascorbate (0.011 g, 0.060 mmol, 0.4 equiv) and copper sulphate pentahydrate (0.007 
g, 0.03 mmol, 0.2 equiv) dissolved in H2O (0.3 mL, were added under vigorous stirring and the 
reaction monitored by TLC (4:1 Pentane:EtOAc). Upon consumption of the starting material the 
reaction mixture was diluted with water (5 mL) and extracted with DCM (3x5 mL). The 
combined organic layers were dried over MgSO4 and the solvent removed in vacuo. The crude 
was then purified with flash chromatography (4:1 Pentane:EtOAc) to afford (R)-4-bromo-2-(4-(4-
bromophenyl)-1H-1,2,3-triazol-1-yl)-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (10c) as an 
orange oil (0.065 g, 0.13 mmol, 96% yield). 
 
Rf: 0.35 (4:1 Pentane:Ethyl Acetate 4:1). 
 
1H NMR (400 MHz, Chloroform-d) δ 8.33 (s, 1H, ArH), 7.87 (dd, J = 7.8, 1.0 Hz, 1H, ArH), 
7.82 – 7.68 (m, 3H, ArH), 7.54 (d, J = 8.5 Hz, 2H, ArH), 7.41 – 7.31 (m, 1H, ArH), 4.90 (s, 1H, 
CCH2), 4.72 (s, 1H, CCH2), 4.58 (d, J = 18.3 Hz, 1H, CH2CMe), 3.75 (d, J = 18.3 Hz, 1H, 
CH2CMe), 3.08 – 2.93 (m, 1H, CH2), 2.86 – 2.75 (m, 1H, CH2), 1.50 (dd, J = 1.5, 0.8 Hz, 3H, 
CH3). 
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13C NMR (101.00 MHz, Chloroform-d) δ  200.0, 171.2, 151.7, 147.1, 139.4, 138.4, 135.0, 
132.0, 130.1, 129.5, 127.3, 124.2, 122.1, 119.0, 117.6, 70.5, 60.4, 46.0, 38.0, 23.3, 21.1, 14.2. 
IR νmax  3157 (w), 3078 (w), 2975 (w), 1727 (s), 1597 (m), 1459 (m), 1266 (s), 1126 (m), 1070 
(s), 1010 (s). 
HRMS (ESI)  calcd for C21H18
79Br2N3O
+ [M+H]+ 485.9811; found 442.9795. 
[α]D25.0 +40.2 (c = 0.2, CHCl3). 
 (R)-2-Amino-5-bromo-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-one (11) 
 
 
Following a reported procedure,25 2-azido-5-bromo-2-(2-methylallyl)-2,3-dihydro-1H-inden-1-
one (7e) (0.050 mg, 0.16 mmol) was dissolved in 3 mL of anhydrous THF under N2 in an 10 mL 
flask. Then triphenylphosphine (0.129 mg, 0.490 mmol, 3 equiv) was added under vigorous 
stirring at 0 °C. The clear solution was monitored by TLC (Pentane:EtOAc 2:1) and left stirring 
until consumption of the starting material. Then the reaction was quenched with water (3 mL) 
and the water phase was extracted three times with EtOAc (3x5 mL).  The crude was then 
purified with flash chromatography (2:1 Pentane:EtOAc) to afford (R)-2-amino-5-bromo-2-(2-
methylallyl)-2,3-dihydro-1H-inden-1-one (11) (0.024 g, 0.086 mmol, 53% yield) as a yellow oil. 
 
Rf: 0.40 (Pentane:Ethyl Acetate 2:1). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.70 – 7.59 (m, 2H, ArH), 7.58 – 7.49 (m, 1H, ArH), 4.87 
(s, 1H, CCH2), 4.75 (s, 1H, CCH2), 3.40 (d, J = 17.6 Hz, 1H, CH2), 2.92 (d, J = 17.6 Hz, 1H, 
CH2), 2.41 (s, 2H, CH2CMe), 1.71 – 1.64 (m, 5H, NH2+CH3). 
 
13C NMR (101.00 MHz, Chloroform-d) δ 208.1, 153.5, 141.2, 133.6, 131.6, 131.0, 130.1, 
126.1, 116.0, 62.9, 46.7, 40.3, 24.3. 
IR νmax  3072 (w), 2926 (w), 2850 (w), 2078 (w), 1719 (s), 1596 (s), 1574 (m), 1416 (w), 1317 
(m), 1205 (m), 1060 (w), 933 (m), 900 (m). 
HRMS (ESI)  calcd for C13H14
79BrNNaO+ [M+Na]+ 302.0151; found 302.0153. 
[α]D25.0 +4.67 (c = 2.4, CHCl3). 
 
 
                                                 
25 R. Rossi Paccani, D. Donati, S. Fusi, L. Latterini, G. Farina, V. Zanirato, M. Olivucci, J. Org. Chem. 2012, 77, 
1738. 
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(S)-2-(Aminomethyl)-2-isobutyl-5-methoxy-2,3-dihydro-1H-inden-1-one (12) 
 
Following a reported procedure,26 substrate 8b (0.040 g, 0.16 mmol) was dissolved in anhydrous 
MeOH (0.6 mL) and CHCl3 (0.9 mL). Then PtO2 (15 mg, 0.066 mmol, 0.4 equiv.) was added in 
one portion and the resulting suspension bubbled with hydrogen for one hour. Then the reaction 
was left stirring under hydrogen atmosphere for 36 hours. The suspension was then filtrated on a 
celite pad that was washed with MeOH (3x5 mL). Flash chromatography in pure EtOAc afforded 
(S)-2-(aminomethyl)-2-isobutyl-5-methoxy-2,3-dihydro-1H-inden-1-one (12) (0.017 g, 0.068 
mmol, 41% yield) as a light yellow oil.  
 
Rf: 0.2 (Ethyl Acetate 100%). 
 
1H NMR (400 MHz, Chloroform-d) δ 7.68 (d, J = 9.2 Hz, 1H, ArH), 6.95 – 6.86 (m, 2H, ArH), 
3.89 (s, 3H, OMe), 3.19 – 2.93 (m, 3H, CH2), 2.73 (d, J = 12.9 Hz, 1H, CH2), 2.12 (br s, 2H, 
NH2), 1.64 – 1.63 (m, 2H, CH2), 1.25 (m, 1H, CH), 0.89 (d, J = 6.4 Hz, 3H, CH3), 0.75 (d, J = 6.4 
Hz, 3H, CH3).  
 
13C NMR (101.00 MHz, Chloroform-d) δ 209.0, 165.8, 156.6, 130.2, 125.8, 115.8, 109.7, 55.8, 
54.2, 49.4, 43.3, 36.6, 25.2, 25.0, 23.8. 
 
IR νmax  3441 (w), 2940 (w), 2886 (m), 1697 (m), 1599 (s), 1492 (w), 1440 (w), 1262 (s), 1092 
(w), 1027 (w), 844 (w) 
HRMS (ESI)  calcd for C15H22NO2
+ [M+H]+ 248.1645; found 248.1645. 
[α]D25.0 +1.1 (c = 1.7, CHCl3). 
 
(R)-6-Fluoro-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-carboxamide (13) 
 
 
 
Following a reported procedure,27 a mixture of (S)-6-fluoro-2-(2-methylallyl)-1-oxo-2,3-dihydro-
1H-indene-2-carbonitrile (8f) (0.050 g, 0.22 mmol)), (Z+E)-acetaldehyde oxime (0.026 mL, 0.44 
mmol, 2 equiv), Pd(OAc)2 (4.9 mg, 0.022 mmol, 0.1 equiv) and triphenylphosphine (0.011 g, 
0.044 mmol, 0.2 equiv) in EtOH:Water in an 1 mL flask (3:1 0.4 mL) were heated to reflux for 3 
                                                 
26 BASF Patent US2003/153568 A1, 2003. 
27
 Kim E.S., Kim H.S., Kim J.N., Tetrahedron Lett. 2009, 50(17), 2973-2975 
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h under nitrogen atmosphere.  The reaction mixture was filtered through a Celite pad and washed 
with EtOH/DCM (5 mL). After removal of solvent and column chromatographic purification 
process (Pentane:EtOAc 1:1) (R)-6-fluoro-2-(2-methylallyl)-1-oxo-2,3-dihydro-1H-indene-2-
carboxamide (13) (0.045 g, 0.18 mmol, 83% yield) was obtained as a yellow oil. 
 
Rf: 0.15 (Pentane:Ethyl Acetate 1:1). 
 
1H NMR (400 MHz, Chloroform-d) δ  7.45 (m, 1H, ArH), 7.42 – 7.30 (m, 2H, ArH), 6.98 (s, 
1H, NH2), 5.57 (s, 1H, NH2), 4.86 (s, 1H, CCH2), 4.78 (s, 1H, CCH2), 3.99 (d, J = 17.8 Hz, 1H, 
CH2), 3.16 (d, J = 17.8 Hz, 1H, CH2), 2.73 (d, J = 13.0 Hz, 1H, CH2CMe), 2.63 (d, J = 13.0 Hz, 
1H, CH2CMe), 1.63 (s, 3H, CH3). 
 
13C NMR (101.00 MHz, Chloroform-d) δ 205.7, 171.5, 162.4 (d, J = 248.8 Hz), 149.5 (d, J = 
2.0 Hz), 140.6, 136.3 (d, J = 7.3 Hz), 128.1 (d, J = 7.9 Hz), 123.8 (d, J = 23.8 Hz), 116.9, 110.19 
(d, J = 22.0 Hz), 61.8, 46.9, 33.7, 23.2. 
IR νmax  3726 (w), 3629 (w), 3599 (w), 3449 (w), 3347 (w), 2271 (w), 1705 (s), 1685 (s), 1610 
(w), 1489 (m), 1444 (w), 1371 (w), 1267 (m), 904 (w), 881 (w). 
HRMS (ESI)  calcd for C14H14FNNaO2
+ [M+Na]+ 270.0901; found 270.0903. 
[α]D25.0 +26.1 (c = 2.6, CHCl3).  
 
7. Result of the XRD experiment 
 
 
A single crystal was grown by slow diffusion of the solution of 8c in EtOAc/heptane mixture. 
Supplementary crystallographic data for this compound have been deposited at Cambridge 
Crystallographic Data Centre (CCDC 1418044) and can be obtained free of charge via 
www.ccdc.cam.ac.uk/data_request/cif.
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9. Spectra of new compounds
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S171 
 
S172 
 
 
S173 
 
 
S174 
 
 
13C 101 MHz 
CDCl3 
 
S175 
 
 
S176 
 
S177 
 
 
 
S178 
 
 
S179 
 
 
13C 101 MHz 
CDCl3 
 
S180 
 
S181 
 
S182 
 
S183 
 
 
 
13C 101 MHz 
CDCl3 
 
S184 
 
S185 
 
 
S186 
 
 
S187 
 
 
 
13C 101 MHz 
CDCl3 
 
S188 
 
 
S189 
 
 
 
 
 
 
S190 
 
 
S191 
 
 
13C 101 MHz 
CDCl3 
 
S192 
 
 
 
S193 
 
 
 
 
 
 
 
S194 
 
 
S195 
 
 
13C 101 MHz 
CDCl3 
 
S196 
 
 
 
S197 
 
 
 
 
 
 
S198 
 
 
S199 
 
 
13C 101 MHz 
CDCl3 
 
S200 
 
 
 
S201 
 
 
 
 
 
 
S202 
 
 
S203 
 
 
 
13C 101 MHz 
CDCl3 
 
S204 
 
 
 
S205 
 
 
 
 
 
 
S206 
 
 
S207 
 
 
 
13C 101 MHz 
CDCl3 
 
S208 
 
 
S209 
 
 
 
 
 
S210 
 
 
S211 
 
 
13C 101 MHz 
CDCl3 
 
S212 
 
 
S213 
 
 
 
 
S214 
 
 
 
S215 
 
 
13C 101 MHz 
CDCl3 
 
S216 
 
 
S217 
 
 
 
 
 
 
S218 
 
 
S219 
 
 
13C 101 MHz 
CDCl3 
 
S220 
 
S221 
 
 
 
 
 
 
S222 
 
 
S223 
 
13C 101 MHz 
CDCl3 
 
S224 
 
 
 
 
S225 
 
 
S226 
 
 
13C 101 MHz 
CDCl3 
 
S227 
 
 
S228 
 
 
S229 
 
 
13C 101 MHz 
CDCl3 
 
S230 
 
 
 
 
S231 
 
 
S232 
 
 
13C 101 MHz 
CDCl3 
 
S233 
 
 
 
 
 
 
 
S234 
 
 
 
S235 
 
 
 
13C 101 MHz 
CDCl3 
 
S236 
 
 
S237 
 
 
S238 
 
 
13C 101 MHz 
CDCl3 
 
S239 
 
 
 
 
 
 
